Microneedle device for extraction and sensing of bodily fluids
First Claim
1. A device for collecting a sample of a biological fluid comprising:
- one or more hollow or porous microneedles, each having a base end and a tip;
a substrate to which the base end is attached or integrated; and
at least one collection chamber suitable for collecting said sample of said biological fluid, said collection chamber selectably in fluid communication with the base end, and wherein said collection chamber comprises a one-way valve and an upper portion which is formed of a deformable material.
3 Assignments
0 Petitions

Accused Products

Abstract
Microneedle devices are provided for controlled sampling of biological fluids in a minimally-invasive, painless, and convenient manner. The microneedle devices permit in vivo sensing or withdrawal of biological fluids from the body, particularly from or through the skin or other tissue barriers, with minimal or no damage, pain, or irritation to the tissue. The microneedle device includes one or more microneedles, preferably in a three-dimensional array, a substrate to which the microneedles are connected, and at least one collection chamber and/or sensor in communication with the microneedles. Preferred embodiments further include a means for inducing biological fluid to be drawn through the microneedles and into the collection chamber for analysis. In a preferred embodiment, this induction is accomplished by use of a pressure gradient, which can be created for example by selectively increasing the interior volume of the collection chamber, which includes an elastic or movable portion engaged to a rigid base. Preferred biological fluids for withdrawal and/or sensing include blood, lymph, interstitial fluid, and intracellular fluid. Examples of analytes in the biological fluid to be measured include glucose, cholesterol, bilirubin, creatine, metabolic enzymes, hemoglobin, heparin, clotting factors, uric acid, carcinoembryonic antigen or other tumor antigens, reproductive hormones, oxygen, pH, alcohol, tobacco metabolites, and illegal drugs.
539 Citations
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 7,909,775 B2
Filed 06/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,914,465 B2
Filed 02/08/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,774 B2
Filed 02/13/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 7,892,183 B2
Filed 07/03/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 7,885,697 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optimized sensor geometry for an implantable glucose sensor | ||
Patent #
US 7,881,763 B2
Filed 05/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 7,899,511 B2
Filed 01/17/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
COOLING SYSTEMS AND METHODS FOR CONDUCTIVE COILS | ||
Patent #
US 20110021863A1
Filed 07/24/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 7,875,047 B2
Filed 01/25/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 7,905,833 B2
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,778 B2
Filed 04/20/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 7,901,354 B2
Filed 05/01/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,777 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,901,365 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
MONITORING METHOD AND/OR APPARATUS | ||
Patent #
US 20110105871A1
Filed 08/04/2010
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Devices, systems, methods and tools for continuous glucose monitoring | ||
Patent #
US 7,949,382 B2
Filed 07/27/2010
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 7,946,984 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transdermal Delivery of Apomorphine Using Microneedles | ||
Patent #
US 20110150946A1
Filed 08/21/2009
|
Current Assignee
US WorldMeds
|
Original Assignee
Abeer M. Al-Ghananeem
|
Transcutaneous analyte sensor | ||
Patent #
US 7,949,381 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for monitoring health and delivering drugs transdermally | ||
Patent #
US 7,931,592 B2
Filed 03/28/2005
|
Current Assignee
Leidos Inc.
|
Original Assignee
Georgetown University, Science Applications International Corporation
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,938,787 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Device and method for determining analyte levels | ||
Patent #
US 7,970,448 B2
Filed 04/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,959,582 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
BIO-ELECTRONIC SYSTEM | ||
Patent #
US 20110184256A1
Filed 08/11/2010
|
Current Assignee
Carlos Alberto Barcelo Rojas
|
Original Assignee
Carlos Alberto Barcelo Rojas
|
ELECTROCHEMICAL SENSOR AND METHOD FOR MANUFACTURING | ||
Patent #
US 20110189762A1
Filed 08/28/2008
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical LLC
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,007,446 B2
Filed 10/19/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 7,988,644 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
DRUG DELIVERY DEVICE INCLUDING TISSUE SUPPORT STRUCTURE | ||
Patent #
US 20110172637A1
Filed 01/08/2010
|
Current Assignee
FluGen Inc., Ratio Inc.
|
Original Assignee
FluGen Inc., Ratio Inc.
|
MICRONEEDLE COMPONENT ASSEMBLY FOR DRUG DELIVERY DEVICE | ||
Patent #
US 20110172609A1
Filed 01/08/2010
|
Current Assignee
FluGen Inc., Ratio Inc.
|
Original Assignee
FluGen Inc., Ratio Inc.
|
ELECTROCHEMICAL SENSOR AND METHOD FOR MANUFACTURING | ||
Patent #
US 20110203941A1
Filed 08/28/2008
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical LLC
|
RAPID DELIVERY AND/OR WITHDRAWAL OF FLUIDS | ||
Patent #
US 20110172510A1
Filed 01/13/2011
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Tissue penetration device | ||
Patent #
US 8,016,774 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Methods and apparatus for lancet actuation | ||
Patent #
US 7,981,056 B2
Filed 06/18/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
WEARABLE DRUG DELIVERY DEVICE INCLUDING INTEGRATED PUMPING AND ACTIVATION ELEMENTS | ||
Patent #
US 20110172645A1
Filed 01/08/2010
|
Current Assignee
FluGen Inc., Ratio Inc.
|
Original Assignee
FluGen Inc., Ratio Inc.
|
System and method for delivering fluid into flexible biological barrier | ||
Patent #
US 8,007,466 B2
Filed 05/19/2005
|
Current Assignee
Nanopass Technologies Ltd.
|
Original Assignee
Nanopass Technologies Ltd.
|
Device and method for variable speed lancet | ||
Patent #
US 7,976,476 B2
Filed 03/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Device and method for determining analyte levels | ||
Patent #
US 7,974,672 B2
Filed 04/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 7,981,055 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
DEVICE AND METHOD FOR DELIVERY OF MICRONEEDLE TO DESIRED DEPTH WITHIN THE SKIN | ||
Patent #
US 20110172639A1
Filed 01/08/2010
|
Current Assignee
FluGen Inc., Ratio Inc.
|
Original Assignee
FluGen Inc., Ratio Inc.
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20110178378A1
Filed 03/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties | ||
Patent #
US 7,988,645 B2
Filed 05/03/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
DRUG DELIVERY DEVICE INCLUDING MULTI-FUNCTIONAL COVER | ||
Patent #
US 20110172638A1
Filed 01/08/2010
|
Current Assignee
FluGen Inc., Ratio Inc.
|
Original Assignee
FluGen Inc., Ratio Inc.
|
Analyte sensing biointerface | ||
Patent #
US 8,060,174 B2
Filed 04/14/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,062,231 B2
Filed 10/11/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
TECHNIQUES AND DEVICES ASSOCIATED WITH BLOOD SAMPLING | ||
Patent #
US 20100256524A1
Filed 03/02/2010
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100228109A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 7,792,562 B2
Filed 12/22/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 7,771,352 B2
Filed 05/01/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100228497A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY | ||
Patent #
US 20100204538A1
Filed 07/24/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 7,831,287 B2
Filed 04/28/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 7,835,777 B2
Filed 12/22/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268047A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
DEVICES, SYSTEMS, METHODS AND TOOLS FOR CONTINUOUS ANALYTE MONITORING | ||
Patent #
US 20100049021A1
Filed 08/20/2009
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
Molecular sieve and zeolite microneedles and preparation thereof | ||
Patent #
US 7,699,819 B2
Filed 02/14/2007
|
Current Assignee
University Hong Kong Science Techn
|
Original Assignee
Hong Kong University of Science and Technology
|
Microneedles, Microneedle Arrays, Methods for Making, and Transdermal and/or Intradermal Applications | ||
Patent #
US 20100121307A1
Filed 11/02/2009
|
Current Assignee
Microfabrica Incorporated
|
Original Assignee
Microfabrica Incorporated
|
METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY | ||
Patent #
US 20100160712A1
Filed 07/24/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY | ||
Patent #
US 20100168501A1
Filed 07/23/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 7,783,333 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
PUNCTURE DEVICE AND FINE PORE FORMATION METHOD | ||
Patent #
US 20100249651A1
Filed 03/31/2010
|
Current Assignee
Sysmex Corporation
|
Original Assignee
Sysmex Corporation
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100274111A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Devices, systems, methods and tools for continuous glucose monitoring | ||
Patent #
US 20100292551A1
Filed 07/27/2010
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
Microneedle Devices and Methods of Manufacture and Use Thereof | ||
Patent #
US 20100312191A1
Filed 08/09/2010
|
Current Assignee
Georgia Tech Research Corporation
|
Original Assignee
Georgia Tech Research Corporation
|
Analyte sensor | ||
Patent #
US 7,857,760 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
GUIDE WIRE AND METHOD FOR ITS USE | ||
Patent #
US 20100318172A1
Filed 06/10/2010
|
Current Assignee
Ulrich Schaefer
|
Original Assignee
Ulrich Schaefer
|
LUBRICIOUS COATINGS | ||
Patent #
US 20090024097A1
Filed 07/01/2008
|
Current Assignee
Covidien LP
|
Original Assignee
Tyco Healthcare Group LP
|
Microneedle with membrane | ||
Patent #
US 20090043250A1
Filed 05/12/2008
|
Current Assignee
Valeritas LLC
|
Original Assignee
Valeritas LLC
|
SENSOR HEAD FOR USE WITH IMPLANTABLE DEVICES | ||
Patent #
US 20090045055A1
Filed 10/28/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System And Method For Delivering Fluid Into Flexible Biological Barrier | ||
Patent #
US 20090069788A1
Filed 05/19/2005
|
Current Assignee
Nanopass Technologies Ltd.
|
Original Assignee
Nanopass Technologies Ltd.
|
MONITORING METHOD AND/OR APPARATUS | ||
Patent #
US 20090069651A1
Filed 08/08/2008
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
IMPLANTABLE ANALYTE SENSOR | ||
Patent #
US 20090062633A1
Filed 11/04/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DEXCORN INC.
|
Microneedle Systems and Apparatus | ||
Patent #
US 20090099522A1
Filed 08/25/2008
|
Current Assignee
Deka Products Limited Partnership
|
Original Assignee
Deka Products Limited Partnership
|
MICRONEEDLE ARRAY WITH DIVERSE NEEDLE CONFIGURATIONS | ||
Patent #
US 20090099427A1
Filed 10/12/2007
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
DEVICES, SYSTEMS, METHODS AND TOOLS FOR CONTINUOUS GLUCOSE MONITORING | ||
Patent #
US 20090131778A1
Filed 11/20/2008
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090156919A1
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090163790A1
Filed 01/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090171179A1
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090187088A1
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
INTEGRATED INTRA-DERMAL DELIVERY, DIAGNOSTIC AND COMMUNICATION SYSTEM | ||
Patent #
US 20090187167A1
Filed 12/17/2008
|
Current Assignee
New World Pharmaceuticals LLC
|
Original Assignee
New World Pharmaceuticals LLC
|
METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY | ||
Patent #
US 20090227829A1
Filed 05/20/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY | ||
Patent #
US 20090234179A1
Filed 05/20/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY | ||
Patent #
US 20090227831A1
Filed 05/20/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
ANALYTE SENSOR | ||
Patent #
US 20090242399A1
Filed 03/25/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and Apparatus Incorporating a Surface Penetration Device | ||
Patent #
US 20080058726A1
Filed 08/30/2006
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
Device, systems, methods and tools for continuous glucose monitoring | ||
Patent #
US 20080154107A1
Filed 12/20/2006
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
LOW OXYGEN IN VIVO ANALYTE SENSOR | ||
Patent #
US 20080208025A1
Filed 05/01/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
BIOINTERFACE WITH MACRO- AND MICRO-ARCHITECTURE | ||
Patent #
US 20080195232A1
Filed 04/15/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Continuous analyte monitor with multi-point self-calibration | ||
Patent #
US 20080234562A1
Filed 03/19/2007
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
Coated Microstructures and Methods of Manufacture Thereof | ||
Patent #
US 20080213461A1
Filed 06/19/2006
|
Current Assignee
Georgia Tech Research Corporation
|
Original Assignee
Georgia Tech Research Corporation
|
Microneedles and Methods for Microinfusion | ||
Patent #
US 20080269666A1
Filed 05/25/2006
|
Current Assignee
Georgia Tech Research Corporation
|
Original Assignee
Georgia Tech Research Corporation
|
ON-DEMAND ANALYTE MONITOR AND METHOD OF USE | ||
Patent #
US 20080312518A1
Filed 06/14/2007
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY | ||
Patent #
US 20080306325A1
Filed 10/02/2007
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
EMKINETICS
|
Method and apparatus for penetrating tissue | ||
Patent #
US 20070167874A1
Filed 02/08/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Don Alden, Dirk Boecker, Dominique Freeman
|
Analyte sensor | ||
Patent #
US 20070197889A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070203410A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070244380A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249919A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Determination of biological conditions using impedance measurements | ||
Patent #
US 20070265512A1
Filed 05/03/2007
|
Current Assignee
Scibase AB
|
Original Assignee
Scibase AB
|
Analyte monitoring device and methods of use | ||
Patent #
US 20060189863A1
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 20060183985A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optimized sensor geometry for an implantable glucose sensor | ||
Patent #
US 20060211921A1
Filed 05/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices, Systems, Methods And Tools For Continuous Glucose Monitoring | ||
Patent #
US 20060219576A1
Filed 03/28/2006
|
Current Assignee
Pent Technologies Inc.
|
Original Assignee
Pent Technologies Inc.
|
Dual insertion set | ||
Patent #
US 20060253085A1
Filed 06/08/2005
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 20060257996A1
Filed 04/14/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20060270923A1
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and methods for enhanced microneedle penetration of biological barriers | ||
Patent #
US 20050137531A1
Filed 05/28/2004
|
Current Assignee
Valeritas LLC
|
Original Assignee
Valeritas LLC
|
Systems and methods for monitoring health and delivering drugs transdermally | ||
Patent #
US 20050182307A1
Filed 03/28/2005
|
Current Assignee
Leidos Inc.
|
Original Assignee
Georgetown University, Science Applications International Corporation, Dermal Systems International Inc.
|
Analyte measurement | ||
Patent #
US 20040096959A1
Filed 12/29/2003
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
LifeScan IP Holdings LLC
|
Device for use in measuring and/or analysing at least one parameter of an external body portion | ||
Patent #
US 20040254546A1
Filed 05/05/2004
|
Current Assignee
LOreal SA
|
Original Assignee
LOreal SA
|
Microneedle devices and production thereof | ||
Patent #
US 20020082543A1
Filed 12/14/2001
|
Current Assignee
Valeritas LLC
|
Original Assignee
Valeritas LLC
|
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 8,123,700 B2
Filed 06/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
TECHNIQUES FOR USE WITH A NAIL PENETRATION DEVICE | ||
Patent #
US 20110301628A1
Filed 05/09/2011
|
Current Assignee
Moshe Gelber, Noah Amit, Ruth Alon, Yossi Gross
|
Original Assignee
Moshe Gelber, Noah Amit, Ruth Alon, Yossi Gross
|
Apparatus and Method for Measuring Physiological Functions | ||
Patent #
US 20110319786A1
Filed 11/22/2010
|
Current Assignee
Johns Hopkins University
|
Original Assignee
Johns Hopkins University
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,079,960 B2
Filed 10/10/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Device for use in measuring and/or analysing at least one parameter of an external body portion | ||
Patent #
US 8,075,483 B2
Filed 10/31/2002
|
Current Assignee
LOreal SA
|
Original Assignee
LOreal SA
|
Porous membranes for use with implantable devices | ||
Patent #
US 8,118,877 B2
Filed 01/17/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Lubricious coatings | ||
Patent #
US 8,128,599 B2
Filed 07/01/2008
|
Current Assignee
Covidien LP
|
Original Assignee
Tyco Healthcare Group LP
|
Analyte sensor | ||
Patent #
US 8,133,178 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,155,723 B2
Filed 01/28/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,157,748 B2
Filed 01/10/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,160,671 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,162,853 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,197,421 B2
Filed 07/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,197,423 B2
Filed 12/14/2010
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Pelikan Technologies Inc.
|
Tissue penetration device | ||
Patent #
US 8,206,317 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,206,319 B2
Filed 08/26/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,211,037 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
MEASURING CELL FOR THE INFRARED ANALYSIS OF FLUIDS, MEASURING SYSTEM HAVING SUCH A MEASURING CELL, AND METHOD FOR PRODUCING SUCH A MEASURING CELL | ||
Patent #
US 20120174658A1
Filed 09/14/2010
|
Current Assignee
Hydac Electronic GmbH
|
Original Assignee
Hydac Electronic GmbH
|
Tissue penetration device | ||
Patent #
US 8,216,154 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,221,334 B2
Filed 12/22/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,235,915 B2
Filed 12/18/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,249,684 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 8,251,921 B2
Filed 06/10/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Microneedle drug delivery device | ||
Patent #
US 8,257,324 B2
Filed 05/21/2007
|
Current Assignee
Georgia Tech Research Corporation
|
Original Assignee
Georgia Tech Research Corporation
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for fluid injection | ||
Patent #
US 8,262,614 B2
Filed 06/01/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for body fluid sampling with hybrid actuation | ||
Patent #
US 8,267,870 B2
Filed 05/30/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Devices, systems, methods and tools for continuous glucose monitoring | ||
Patent #
US 8,280,476 B2
Filed 03/28/2006
|
Current Assignee
Pent Technologies Inc.
|
Original Assignee
ArKal Medical Inc.
|
Method and apparatus for an improved sample capture device | ||
Patent #
US 8,282,576 B2
Filed 09/29/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 8,282,577 B2
Filed 06/15/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,287,453 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,290,560 B2
Filed 11/18/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method of manufacturing a fluid sampling device with improved analyte detecting member configuration | ||
Patent #
US 8,296,918 B2
Filed 08/23/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor inserter system | ||
Patent #
US 8,313,434 B2
Filed 03/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,333,710 B2
Filed 10/05/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,421 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,419 B2
Filed 10/04/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,420 B2
Filed 03/24/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,343,075 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,360,991 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,360,992 B2
Filed 11/25/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,366,637 B2
Filed 12/03/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 8,372,016 B2
Filed 09/30/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,382,682 B2
Filed 02/06/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,382,683 B2
Filed 03/07/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 8,388,551 B2
Filed 05/27/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,394,021 B2
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,403,864 B2
Filed 05/01/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,414,503 B2
Filed 03/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 8,423,114 B2
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,428,678 B2
Filed 05/16/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for magnetic induction therapy | ||
Patent #
US 8,430,805 B2
Filed 05/20/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 8,430,828 B2
Filed 01/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for magnetic induction therapy | ||
Patent #
US 8,435,166 B2
Filed 05/20/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,435,190 B2
Filed 01/19/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Apparatus and method for penetration with shaft having a sensor for sensing penetration depth | ||
Patent #
US 8,439,872 B2
Filed 04/26/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,457,708 B2
Filed 12/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,463,350 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,483,791 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,491,500 B2
Filed 04/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,496,601 B2
Filed 04/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Manufacturing electrochemical sensor module | ||
Patent #
US 8,506,740 B2
Filed 11/12/2009
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical LLC
|
Sensor head for use with implantable devices | ||
Patent #
US 8,509,871 B2
Filed 10/28/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,519 B2
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,516 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,527,025 B1
Filed 11/22/1999
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,527,026 B2
Filed 03/02/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,548,551 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,556,829 B2
Filed 01/27/2009
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Low-pressure packaging for fluid devices | ||
Patent #
US 8,561,795 B2
Filed 11/15/2012
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Tissue penetration device | ||
Patent #
US 8,562,545 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,565,849 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for monitoring health and delivering drugs transdermally | ||
Patent #
US 8,568,315 B2
Filed 04/13/2011
|
Current Assignee
Science Applications International Corporation
|
Original Assignee
Georgetown University, Science Applications International Corporation
|
Transcutaneous analyte sensor | ||
Patent #
US 8,571,625 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for a multi-use body fluid sampling device with analyte sensing | ||
Patent #
US 8,574,168 B2
Filed 03/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus using optical techniques to measure analyte levels | ||
Patent #
US 8,574,895 B2
Filed 12/30/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,579,831 B2
Filed 10/06/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Microneedle electrode | ||
Patent #
US 8,588,884 B2
Filed 05/28/2010
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,615,282 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,622,905 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,622,930 B2
Filed 07/18/2011
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,202,231 B2
Filed 04/23/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,636,673 B2
Filed 12/01/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sampling module device and method | ||
Patent #
US 8,641,643 B2
Filed 04/27/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means | ||
Patent #
US 8,641,644 B2
Filed 04/23/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
FLUID EXTRACTION OR FILTRATION DEVICE, ASSOCIATED MATERIALS AND METHODS | ||
Patent #
US 20140052084A1
Filed 10/25/2013
|
Current Assignee
Renephra Limited
|
Original Assignee
Renephra Limited
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,663,109 B2
Filed 03/29/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Lubricious coatings | ||
Patent #
US 8,663,737 B2
Filed 01/26/2012
|
Current Assignee
Covidien LP
|
Original Assignee
Covidien LP
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for improving fluidic flow and sample capture | ||
Patent #
US 8,668,656 B2
Filed 12/31/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Wearable drug delivery device having spring drive and sliding actuation mechanism | ||
Patent #
US 8,668,675 B2
Filed 11/03/2011
|
Current Assignee
FluGen Inc.
|
Original Assignee
FluGen Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,676,287 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,676,288 B2
Filed 06/22/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,679,033 B2
Filed 06/16/2011
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,690,775 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,690,796 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,700,117 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for analyte measurement test time | ||
Patent #
US 8,652,831 B2
Filed 03/26/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte measurement device with a single shot actuator | ||
Patent #
US 8,702,624 B2
Filed 01/29/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Electrochemical sensor and method for manufacturing | ||
Patent #
US 8,702,932 B2
Filed 08/28/2008
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical Inc.
|
Microneedle devices and methods of manufacture and use thereof | ||
Patent #
US 8,708,966 B2
Filed 08/09/2010
|
Current Assignee
Georgia Tech Research Corporation
|
Original Assignee
Georgia Tech Research Corporation
|
Transcutaneous analyte sensor | ||
Patent #
US 8,721,545 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electric lancet actuator | ||
Patent #
US 8,721,671 B2
Filed 07/06/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,731,630 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,777,853 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Medical testing apparatus | ||
Patent #
US D709,193 S1
Filed 03/15/2013
|
Current Assignee
Research Institute at Nationwide Childrens Hospital
|
Original Assignee
Research Institute at Nationwide Childrens Hospital
|
Body fluid sampling device with a capacitive sensor | ||
Patent #
US 8,784,335 B2
Filed 07/25/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,006 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,954 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,955 B2
Filed 06/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,953 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,801,611 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for penetrating tissue | ||
Patent #
US 8,808,201 B2
Filed 01/15/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Systems and interfaces for blood sampling | ||
Patent #
US 8,808,202 B2
Filed 11/09/2011
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 8,812,072 B2
Filed 04/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Intraocular Injection Device | ||
Patent #
US 20140236098A1
Filed 10/04/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Delivering and/or receiving fluids | ||
Patent #
US 8,821,412 B2
Filed 11/19/2012
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 8,825,127 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Delivering and/or receiving fluids | ||
Patent #
US 8,827,971 B2
Filed 04/26/2012
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Printable hydrogels for biosensors | ||
Patent #
US 8,828,203 B2
Filed 05/20/2005
|
Current Assignee
Sanofi-Aventis SA
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Membrane for use with implantable devices | ||
Patent #
US 8,840,552 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method for penetrating tissue | ||
Patent #
US 8,845,549 B2
Filed 12/02/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,845,550 B2
Filed 12/03/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,858,434 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
MECHANICAL LEECH SYSTEM | ||
Patent #
US 20140309619A1
Filed 04/09/2014
|
Current Assignee
Biomine Innovations LLC
|
Original Assignee
BioMime Innovations LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,272 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
MICRONEEDLE ARRAYS FOR BIOSENSING AND DRUG DELIVERY | ||
Patent #
US 20140336487A1
Filed 08/31/2012
|
Current Assignee
National Technology Engineering Solutions Of Sandia LLC
|
Original Assignee
Joseph Wang, Joshua Ray Windmiller, Thayne L. Edwards, Phillip Miller, Ronen Polsky, Roger Narayan
|
Measuring cell for the infrared analysis of fluids, measuring system having such a measuring cell, and method for producing such a measuring cell | ||
Patent #
US 8,890,075 B2
Filed 09/14/2010
|
Current Assignee
Hydac Electronic GmbH
|
Original Assignee
Hydac Electronic GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,905,945 B2
Filed 03/29/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Don Alden, Dirk Boecker, Dominique M. Freeman
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 8,911,369 B2
Filed 12/15/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,923,947 B2
Filed 07/23/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Medical marking apparatus | ||
Patent #
US D721,435 S1
Filed 01/15/2013
|
Current Assignee
Research Institute at Nationwide Childrens Hospital
|
Original Assignee
Research Institute at Nationwide Childrens Hospital
|
Method and apparatus for treatment of ocular tissue using combine modalities | ||
Patent #
US 8,945,101 B2
Filed 05/02/2011
|
Current Assignee
ALeyeGN Technologies LLC
|
Original Assignee
Seros Medical LLC
|
Method and apparatus for an improved sample capture device | ||
Patent #
US 8,945,910 B2
Filed 06/19/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,965,476 B2
Filed 04/18/2011
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Manufacturing electrochemical sensor module | ||
Patent #
US 8,951,377 B2
Filed 05/21/2012
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and devices for performing electrical stimulation to treat various conditions | ||
Patent #
US 9,002,477 B2
Filed 11/20/2013
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Method and apparatus for electrical stimulation therapy | ||
Patent #
US 9,005,102 B2
Filed 04/26/2012
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Method and apparatus for the delivery of photochemical (cross-linking) treatment to scleral tissue | ||
Patent #
US 9,005,099 B2
Filed 02/14/2012
|
Current Assignee
ALeyeGN Technologies LLC
|
Original Assignee
Seros Medical LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated intra-dermal delivery, diagnostic and communication system | ||
Patent #
US 9,022,973 B2
Filed 12/17/2008
|
Current Assignee
New World Pharmaceuticals LLC
|
Original Assignee
New World Pharmaceuticals LLC
|
Sampling devices and methods involving relatively little pain | ||
Patent #
US 9,033,898 B2
Filed 06/22/2011
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Method and apparatus using optical techniques to measure analyte levels | ||
Patent #
US 9,034,639 B2
Filed 06/26/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Monitoring or feedback systems and methods | ||
Patent #
US 9,041,541 B2
Filed 01/28/2011
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 9,044,199 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrochemical sensor and method for manufacturing | ||
Patent #
US 9,044,178 B2
Filed 08/28/2008
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical LLC
|
Transcutaneous analyte sensor | ||
Patent #
US 9,060,742 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,072,842 B2
Filed 07/31/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transdermal Porator and Patch System and Method for Using Same | ||
Patent #
US 20150190074A1
Filed 01/03/2014
|
Current Assignee
Passport Technologies Inc.
|
Original Assignee
Stuart Mcrae
|
Transcutaneous analyte sensor | ||
Patent #
US 9,078,626 B2
Filed 03/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte measurement device with a single shot actuator | ||
Patent #
US 9,089,294 B2
Filed 01/16/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,089,678 B2
Filed 05/21/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Devices and techniques associated with diagnostics, therapies, and other applications, including skin-associated applications | ||
Patent #
US 9,113,836 B2
Filed 03/02/2010
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Plasma or serum production and removal of fluids under reduced pressure | ||
Patent #
US 9,119,578 B2
Filed 04/26/2012
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Low pain penetrating member | ||
Patent #
US 9,144,401 B2
Filed 12/12/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Biomarker Detection Device for Monitoring Peptide and Non-Peptide Markers | ||
Patent #
US 20150276758A1
Filed 09/11/2014
|
Current Assignee
Anteneh Addisu
|
Original Assignee
Anteneh Addisu
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 9,155,496 B2
Filed 02/18/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Microneedle patch container | ||
Patent #
US 9,168,200 B2
Filed 09/20/2012
|
Current Assignee
CosMED Pharmaceutical Co. Ltd.
|
Original Assignee
CosMED Pharmaceutical Co. Ltd.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,186,468 B2
Filed 01/14/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Body fluid sampling module with a continuous compression tissue interface surface | ||
Patent #
US 9,226,699 B2
Filed 11/09/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 9,248,267 B2
Filed 07/18/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte sensor | ||
Patent #
US 9,247,900 B2
Filed 06/04/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,247,901 B2
Filed 08/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Printable hydrogel for biosensors | ||
Patent #
US 9,261,476 B2
Filed 04/01/2014
|
Current Assignee
Sanofi-Aventis SA
|
Original Assignee
Sanofi S.A.
|
Systems and methods for collecting fluid from a subject | ||
Patent #
US 9,295,417 B2
Filed 04/26/2012
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Microneedle devices and production thereof | ||
Patent #
US 9,302,903 B2
Filed 12/14/2001
|
Current Assignee
Valeritas LLC
|
Original Assignee
Georgia Tech Research Corporation
|
Tissue penetration device | ||
Patent #
US 9,314,194 B2
Filed 01/11/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
APPARATUS AND METHOD FOR DETECTING AND/OR MONITORING ONE OR MORE COMPOUNDS IN BLOOD | ||
Patent #
US 20160113561A1
Filed 12/08/2015
|
Current Assignee
David R. Elmaleh
|
Original Assignee
David R. Elmaleh
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensor head for use with implantable devices | ||
Patent #
US 9,328,371 B2
Filed 07/16/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for monitoring health and delivering drugs transdermally | ||
Patent #
US 9,332,937 B2
Filed 09/25/2013
|
Current Assignee
Leidos Inc.
|
Original Assignee
Leidos Inc., Georgetown University
|
Device and method for determining analyte levels | ||
Patent #
US 9,339,223 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 9,339,612 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for transdermal stimulation over the palmar and plantar surfaces | ||
Patent #
US 9,339,641 B2
Filed 03/15/2013
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Method and apparatus for a variable user interface | ||
Patent #
US 9,351,680 B2
Filed 10/14/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method of making coated microstructures | ||
Patent #
US 9,364,426 B2
Filed 02/20/2014
|
Current Assignee
Georgia Tech Research Corporation
|
Original Assignee
Georgia Tech Research Corporation
|
Cam drive for managing disposable penetrating member actions with a single motor and motor and control system | ||
Patent #
US 9,375,169 B2
Filed 01/29/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for analyte detecting device | ||
Patent #
US 9,386,944 B2
Filed 04/10/2009
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Methods and devices for performing electrical stimulation to treat various conditions | ||
Patent #
US 9,387,338 B2
Filed 04/01/2015
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Medical marking apparatus | ||
Patent #
US D761,427 S1
Filed 12/11/2014
|
Current Assignee
Research Institute at Nationwide Childrens Hospital
|
Original Assignee
Research Institute at Nationwide Childrens Hospital
|
Transcutaneous analyte sensor | ||
Patent #
US 9,414,777 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,420,968 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 9,427,532 B2
Filed 09/29/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Device and method for determining analyte levels | ||
Patent #
US 9,439,589 B2
Filed 11/25/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrochemical sensor module | ||
Patent #
US 9,445,755 B2
Filed 11/12/2009
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical LLC
|
Analyte sensor | ||
Patent #
US 9,451,908 B2
Filed 12/19/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Injection needle and device | ||
Patent #
US 9,457,183 B2
Filed 06/13/2012
|
Current Assignee
TRIPEP AB
|
Original Assignee
TRIPEP AB
|
Electrochemical sensor and method for manufacturing | ||
Patent #
US 9,459,228 B2
Filed 04/21/2014
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method for penetrating tissue | ||
Patent #
US 9,498,160 B2
Filed 09/29/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Manufacturing electrochemical sensor modules | ||
Patent #
US 9,504,162 B2
Filed 05/18/2012
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical Inc.
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 9,504,413 B2
Filed 04/15/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,510,782 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Mechanical leech system | ||
Patent #
US 9,522,230 B2
Filed 04/09/2014
|
Current Assignee
Biomine Innovations LLC
|
Original Assignee
BioMime Innovations LLC
|
Membrane for use with implantable devices | ||
Patent #
US 9,532,741 B2
Filed 07/25/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
MICRONEEDLE UNIT AND INJECTION DEVICE | ||
Patent #
US 20170007812A1
Filed 01/28/2015
|
Current Assignee
ASTI Corporation
|
Original Assignee
ASTI Corporation
|
MICRONEEDLE ARRAY DEVICE AND METHOD OF MAKING | ||
Patent #
US 20160157764A1
Filed 12/03/2014
|
Current Assignee
STMicroelectronics SRL
|
Original Assignee
Imast Scarl
|
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means | ||
Patent #
US 9,560,993 B2
Filed 12/20/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for improving fluidic flow and sample capture | ||
Patent #
US 9,561,000 B2
Filed 12/10/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 9,579,053 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,585,607 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,603,557 B2
Filed 05/13/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
METHOD FOR THE MASK-ETCHING OF A PIERCING ELEMENT | ||
Patent #
US 20170086726A1
Filed 12/14/2016
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Roche Diabetes Care Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,610,031 B2
Filed 04/13/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Cooling systems and methods for conductive coils | ||
Patent #
US 9,610,459 B2
Filed 07/24/2009
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Method and apparatus for transdermal stimulation over the palmar and plantar surfaces | ||
Patent #
US 9,630,004 B2
Filed 03/29/2016
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
TECHNIQUES AND DEVICES ASSOCIATED WITH BLOOD SAMPLING | ||
Patent #
US 20170127990A1
Filed 12/21/2016
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Analyte sensor | ||
Patent #
US 9,668,677 B2
Filed 10/26/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and method for detecting and\or monitoring one or more compounds in blood | ||
Patent #
US 9,675,284 B2
Filed 11/01/2013
|
Current Assignee
1QB Information Technologies Inc.
|
Original Assignee
David R. Elmaleh
|
Sampling module device and method | ||
Patent #
US 9,694,144 B2
Filed 12/03/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,724,021 B2
Filed 12/08/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte sensor | ||
Patent #
US 9,724,028 B2
Filed 11/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Delivering and/or receiving fluids | ||
Patent #
US 9,730,624 B2
Filed 07/11/2014
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Microneedle arrays for biosensing and drug delivery | ||
Patent #
US 9,737,247 B2
Filed 08/31/2012
|
Current Assignee
National Technology Engineering Solutions Of Sandia LLC
|
Original Assignee
National Technology Engineering Solutions Of Sandia LLC, North Carolina State University, Regents of the University of California
|
Microneedle arrays for biosensing and drug delivery | ||
Patent #
US 9,743,870 B2
Filed 12/10/2015
|
Current Assignee
National Technology Engineering Solutions Of Sandia LLC
|
Original Assignee
National Technology Engineering Solutions Of Sandia LLC, North Carolina State University, Regents of the University of California
|
Electrochemical sensor and method for manufacturing | ||
Patent #
US 9,746,440 B2
Filed 05/07/2015
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical LLC
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 9,757,061 B2
Filed 09/01/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and devices for performing electrical stimulation to treat various conditions | ||
Patent #
US 9,757,584 B2
Filed 02/29/2016
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 9,775,543 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and techniques associated with diagnostics, therapies, and other applications, including skin-associated applications | ||
Patent #
US 9,775,551 B2
Filed 07/13/2015
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Method and apparatus for a fluid sampling device | ||
Patent #
US 9,775,553 B2
Filed 10/01/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte sensing biointerface | ||
Patent #
US 9,788,766 B2
Filed 05/19/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,795,334 B2
Filed 07/09/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Methods and apparatus for lancet actuation | ||
Patent #
US 9,795,747 B2
Filed 06/02/2011
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 9,801,572 B2
Filed 06/18/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 9,802,007 B2
Filed 11/18/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Sensor head for use with implantable devices | ||
Patent #
US 9,804,114 B2
Filed 03/02/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Fluid extraction or filtration device, associated materials and methods | ||
Patent #
US 9,808,377 B2
Filed 10/25/2013
|
Current Assignee
Renephra Limited
|
Original Assignee
Renephra Limited
|
Transcutaneous analyte sensor | ||
Patent #
US 9,814,414 B2
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for a fluid sampling device | ||
Patent #
US 9,820,684 B2
Filed 06/03/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,143 B2
Filed 06/05/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,176 B2
Filed 07/12/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Body fluid sampling device with capacitive sensor | ||
Patent #
US 9,839,386 B2
Filed 06/12/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Textile-based printable electrodes for electrochemical sensing | ||
Patent #
US 9,844,339 B2
Filed 09/04/2015
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,907,502 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transdermal porator and patch system and method for using same | ||
Patent #
US 9,918,665 B2
Filed 01/03/2014
|
Current Assignee
Passport Technologies Inc.
|
Original Assignee
Nitto Denko Corporation
|
Device and method for determining analyte levels | ||
Patent #
US 9,931,067 B2
Filed 09/13/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Miniaturized sub-nanoampere sensitivity low-noise potentiostat system | ||
Patent #
US 9,933,387 B1
Filed 09/02/2015
|
Current Assignee
Biolinq Incorporated
|
Original Assignee
Biolinq Incorporated
|
Tissue penetration device | ||
Patent #
US 9,937,298 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte detection system and method for intradermal implantation of biocompatible optode nanosensors | ||
Patent #
US 9,974,471 B1
Filed 12/23/2014
|
Current Assignee
Verily Life Sciences LLC
|
Original Assignee
Verily Life Sciences LLC
|
Analyte sensor | ||
Patent #
US 9,986,942 B2
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Diagnostic/drug delivery “sense-respond” devices, systems, and uses thereof | ||
Patent #
US 9,987,427 B1
Filed 06/22/2015
|
Current Assignee
National Technology Engineering Solutions Of Sandia LLC
|
Original Assignee
National Technology Engineering Solutions Of Sandia LLC
|
Microneedle deposition method | ||
Patent #
US 9,993,423 B2
Filed 10/20/2011
|
Current Assignee
CosMED Pharmaceutical Co. Ltd.
|
Original Assignee
CosMED Pharmaceutical Co. Ltd.
|
Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode | ||
Patent #
US 10,004,434 B1
Filed 03/15/2013
|
Current Assignee
Georgetown University
|
Original Assignee
Georgetown University
|
Systems and methods for subretinal delivery of therapeutic agents | ||
Patent #
US 10,010,447 B2
Filed 12/18/2013
|
Current Assignee
Alcon Incorporated
|
Original Assignee
Novartis Ag
|
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | ||
Patent #
US 10,010,499 B2
Filed 11/03/2015
|
Current Assignee
Merial Incorporated
|
Original Assignee
Georgia Tech Research Corporation, Merial Incorporated
|
Analyte sensor | ||
Patent #
US 10,022,078 B2
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Low pain penetrating member | ||
Patent #
US 10,034,628 B2
Filed 12/20/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transdermal microneedle array patch and method for manufacturing the same | ||
Patent #
US 10,034,636 B2
Filed 05/03/2014
|
Current Assignee
Micro Nipple Technology Co. Ltd.
|
Original Assignee
Micro Nipple Technology Co. Ltd.
|
Membrane for use with implantable devices | ||
Patent #
US 10,039,480 B2
Filed 02/11/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transdermal microneedle continuous monitoring system | ||
Patent #
US 10,070,820 B2
Filed 04/29/2014
|
Current Assignee
Micro Nipple Technology Co. Ltd.
|
Original Assignee
Micro Nipple Technology Co. Ltd.
|
Tissue-penetrating electrochemical sensor featuring a co-electrodeposited thin film comprised of polymer and bio-recognition element | ||
Patent #
US 10,092,207 B1
Filed 05/09/2017
|
Current Assignee
Biolinq Incorporated
|
Original Assignee
Biolinq Incorporated
|
Porous microneedles through sacrificial sugar incorporation, analyte detection system, and method for intradermal optode nanosensor implantation | ||
Patent #
US 10,098,574 B1
Filed 07/07/2015
|
Current Assignee
Verily Life Sciences LLC
|
Original Assignee
Verily Life Sciences LLC
|
Interstitial fluid sampling above microneedle array | ||
Patent #
US 10,105,080 B1
Filed 12/29/2014
|
Current Assignee
Verily Life Sciences LLC
|
Original Assignee
Verily Life Sciences LLC
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 10,136,844 B2
Filed 11/18/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Microneedle arrays for biosensing and drug delivery | ||
Patent #
US 10,136,846 B2
Filed 08/25/2017
|
Current Assignee
Regents of the University of California
|
Original Assignee
National Technology Engineering Solutions Of Sandia LLC, North Carolina State University, Regents of the University of California
|
Plasma or serum production and removal of fluids under reduced pressure | ||
Patent #
US 10,188,335 B2
Filed 07/22/2015
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
MEDICAL DEVICES WITH MICRONEEDLE ARRAYS AND METHODS FOR OPERATING SUCH MEDICAL DEVICES | ||
Patent #
US 20190090811A1
Filed 09/28/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 10,265,000 B2
Filed 08/03/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrochemical sensor module | ||
Patent #
US 10,278,632 B2
Filed 09/19/2016
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical LLC
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 10,299,712 B2
Filed 09/05/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,314,525 B2
Filed 01/06/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and methods for transdermal sensing of analytes in interstitial fluid and associated data transmission systems | ||
Patent #
US 10,321,858 B2
Filed 08/14/2015
|
Current Assignee
Proteadx Inc.
|
Original Assignee
Proteadx Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 10,327,638 B2
Filed 10/30/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensing health using fluid sensors in feminine hygiene products | ||
Patent #
US 10,349,834 B2
Filed 12/30/2016
|
Current Assignee
Palo Alto Research Center Inc.
|
Original Assignee
Palo Alto Research Center Inc.
|
Analyte sensor | ||
Patent #
US 10,349,873 B2
Filed 04/27/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 10,376,188 B2
Filed 09/21/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated intra-dermal delivery, diagnostic and communication system | ||
Patent #
US 10,384,005 B2
Filed 03/31/2015
|
Current Assignee
New World Pharmaceuticals LLC
|
Original Assignee
New World Pharmaceuticals LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,524,703 B2
Filed 01/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Medical devices with microneedle arrays and methods for operating such medical devices | ||
Patent #
US 10,524,730 B2
Filed 09/28/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Fluid extraction and drug delivery system and methods using microneedles | ||
Patent #
US 10,542,922 B2
Filed 03/26/2014
|
Current Assignee
Columbia University
|
Original Assignee
Trustees Of Columbia University In The City Of New York
|
Delivering and/or receiving material with respect to a subject surface | ||
Patent #
US 10,543,310 B2
Filed 11/11/2016
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Radiofrequency ablation pump | ||
Patent #
US D875,255 S1
Filed 05/30/2018
|
Current Assignee
Avent Incorporated
|
Original Assignee
Avent Incorporated
|
Intradermal biosensor | ||
Patent #
US D875,254 S1
Filed 06/08/2018
|
Current Assignee
Biolinq Incorporated
|
Original Assignee
Biolinq Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,137 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,136 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,135 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,617,336 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices, systems, and methods for sample collection | ||
Patent #
US 10,638,963 B2
Filed 08/17/2018
|
Current Assignee
Drawbridge Health Inc.
|
Original Assignee
Drawbridge Health Inc.
|
Medical testing apparatus and method of use | ||
Patent #
US 10,653,354 B2
Filed 03/12/2014
|
Current Assignee
Ohio State Innovation Foundation
|
Original Assignee
Research Institute at Nationwide Childrens Hospital
|
Analyte sensing biointerface | ||
Patent #
US 10,667,729 B2
Filed 06/27/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 10,667,730 B2
Filed 10/16/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 10,702,193 B2
Filed 01/14/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,709,364 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,362 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,363 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,716,498 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,722,152 B2
Filed 11/05/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device for sample collection | ||
Patent #
US D892,310 S1
Filed 07/09/2018
|
Current Assignee
Drawbridge Health Inc.
|
Original Assignee
Drawbridge Health Inc.
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,743,801 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Microneedle unit and injection device | ||
Patent #
US 10,744,311 B2
Filed 01/28/2015
|
Current Assignee
ASTI Corporation
|
Original Assignee
ASTI Corporation
|
Method and apparatus for transdermal stimulation over the palmar and plantar surfaces | ||
Patent #
US 10,786,669 B2
Filed 03/30/2017
|
Current Assignee
Emkinetics Inc.
|
Original Assignee
Emkinetics Inc.
|
Analyte sensor | ||
Patent #
US 10,799,158 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,159 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Delivering and/or receiving fluids | ||
Patent #
US 10,799,166 B2
Filed 06/27/2017
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Analyte sensor | ||
Patent #
US 10,813,577 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,576 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Radiofrequency ablation pump assembly | ||
Patent #
US D900,321 S1
Filed 12/28/2018
|
Current Assignee
Avent Incorporated
|
Original Assignee
Avent Incorporated
|
Single head pump unit | ||
Patent #
US D900,323 S1
Filed 12/28/2018
|
Current Assignee
Avent Incorporated
|
Original Assignee
Avent Incorporated
|
Radiofrequency ablation pump and generator assembly | ||
Patent #
US D900,322 S1
Filed 12/28/2018
|
Current Assignee
Avent Incorporated
|
Original Assignee
Avent Incorporated
|
Protective release sheet for microneedle patch | ||
Patent #
US 10,821,275 B2
Filed 06/25/2013
|
Current Assignee
CosMED Pharmaceutical Co. Ltd.
|
Original Assignee
CosMED Pharmaceutical Co. Ltd.
|
Systems and methods for collecting fluid from a subject | ||
Patent #
US 10,835,163 B2
Filed 01/05/2016
|
Current Assignee
Seventh Sense Biosystems Inc.
|
Original Assignee
Seventh Sense Biosystems Inc.
|
Method for the mask-etching of a piercing element | ||
Patent #
US 10,842,425 B2
Filed 12/14/2016
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Roche Diabetes Care Inc.
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,856,787 B2
Filed 07/31/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Porous microneedles through sacrificial sugar incorporation, analyte detection system, and method for intradermal optode nanosensor implantation | ||
Patent #
US 10,863,932 B1
Filed 09/10/2018
|
Current Assignee
Verily Life Sciences LLC
|
Original Assignee
Verily Life Sciences LLC
|
Cartridge assemblies for storing biological samples | ||
Patent #
US 10,888,259 B2
Filed 11/15/2019
|
Current Assignee
Drawbridge Health Inc.
|
Original Assignee
Drawbridge Health Inc.
|
Microneedle device for transport of molecules across tissue | ||
Patent #
US 6,503,231 B1
Filed 06/10/1998
|
Current Assignee
Valeritas LLC
|
Original Assignee
Georgia Tech Research Corporation
|
Microneedle devices and methods of manufacture and use thereof | ||
Patent #
US 6,334,856 B1
Filed 05/21/1999
|
Current Assignee
Valeritas LLC
|
Original Assignee
Georgia Tech Research Corporation
|
Apparatus and method for manufacturing an intracutaneous microneedle array | ||
Patent #
US 6,312,612 B1
Filed 06/09/1999
|
Current Assignee
Corium Inc.
|
Original Assignee
Procter Gamble Company
|
Stacked microneedle systems | ||
Patent #
US 20010053891A1
Filed 12/22/2000
|
Current Assignee
Valeritas Inc.
|
Original Assignee
Valeritas Inc.
|
Interstitial fluid collection and constituent measurement | ||
Patent #
US 6,080,116 A
Filed 10/09/1998
|
Current Assignee
Integ Incorporated
|
Original Assignee
Integ Incorporated
|
Transcorneal drug-release system | ||
Patent #
US 6,132,755 A
Filed 06/16/1998
|
Current Assignee
Boehringer Ingelheim Promeco SA de CV
|
Original Assignee
Boehringer Ingelheim Promeco SA de CV
|
Acrylic microchannels and their use in electrophoretic applications | ||
Patent #
US 5,858,188 A
Filed 04/04/1996
|
Current Assignee
Monogram Biosciences Inc.
|
Original Assignee
Aclara Biosciences Inc
|
Programmable control and mounting system for transdermal drug applicator | ||
Patent #
US 5,865,786 A
Filed 06/07/1995
|
Current Assignee
Drug Delivery Systems Incorporated
|
Original Assignee
Drug Delivery Systems Incorporated
|
Microfluidic devices and systems | ||
Patent #
US 5,876,675 A
Filed 08/05/1997
|
Current Assignee
Caliper Life Sciences Incorporated
|
Original Assignee
Caliper Holdings Incorporated
|
Method and apparatus for disruption of the epidermis | ||
Patent #
US 5,879,326 A
Filed 04/25/1997
|
Current Assignee
Massachusetts General Hospital
|
Original Assignee
Massachusetts General Hospital
|
Thermoreversible hydrogels comprising linear copolymers and their use in electrophoresis | ||
Patent #
US 5,883,211 A
Filed 04/23/1996
|
Current Assignee
SOANE BIOSCIENCES
|
Original Assignee
Aclara Biosciences Inc
|
Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers | ||
Patent #
US 5,722,397 A
Filed 06/06/1995
|
Current Assignee
Nitto Denko Corporation
|
Original Assignee
Altia Technology
|
Microsampling device and method of construction | ||
Patent #
US 5,801,057 A
Filed 03/22/1996
|
Current Assignee
Kumetrix Incorporated
|
Original Assignee
Kumetrix Incorporated
|
Analyte-controlled liquid delivery device and analyte monitor | ||
Patent #
US 5,807,375 A
Filed 11/02/1995
|
Current Assignee
Elan Corporation PLC
|
Original Assignee
Elan Medical Technologies Ireland Ltd.
|
Skin perforating apparatus for transdermal medication | ||
Patent #
US 5,843,114 A
Filed 05/23/1995
|
Current Assignee
Samsung Electro Mechanics Co Limited
|
Original Assignee
Samsung Electro Mechanics Co Limited
|
Fourier detection of species migrating in a microchannel | ||
Patent #
US 5,852,495 A
Filed 09/30/1997
|
Current Assignee
Caliper Life Sciences Incorporated
|
Original Assignee
Caliper Holdings Incorporated
|
Intradermal drug delivery device and method for intradermal delivery of drugs | ||
Patent #
US 5,848,991 A
Filed 04/25/1997
|
Current Assignee
Elan Pharma International Limited
|
Original Assignee
ELAN MEDICAL TECHNOLOGIES LIMITED ATHLONE CO.
|
IC-processed microneedles | ||
Patent #
US 5,591,139 A
Filed 06/06/1994
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Active programmable electronic devices for molecular biological analysis and diagnostics | ||
Patent #
US 5,605,662 A
Filed 11/01/1993
|
Current Assignee
Gamida for Life B.V.
|
Original Assignee
Nanogen Inc.
|
Method for producing tips for atomic force microscopes | ||
Patent #
US 5,611,942 A
Filed 03/02/1995
|
Current Assignee
Toshiba Corporation
|
Original Assignee
Toshiba Corporation
|
Needle devices for medical use | ||
Patent #
US 5,611,809 A
Filed 11/06/1995
|
Current Assignee
Owen Mumford
|
Original Assignee
Owen Mumford
|
Skin perforating device for transdermal medication | ||
Patent #
US 5,611,806 A
Filed 05/23/1995
|
Current Assignee
Metallgesellschaft AG
|
Original Assignee
Samsung Electro Mechanics Co Limited
|
Apparatus for preparing skin in advance | ||
Patent #
US 5,618,295 A
Filed 10/14/1994
|
Current Assignee
Samsung Electro Mechanics Co Limited
|
Original Assignee
Samsung Electro Mechanics Co Limited
|
Molecular biological diagnostic systems including electrodes | ||
Patent #
US 5,632,957 A
Filed 09/09/1994
|
Current Assignee
Gamida for Life B.V.
|
Original Assignee
NANOGEN
|
Polymer micromold and fabrication process | ||
Patent #
US 5,658,515 A
Filed 09/25/1995
|
Current Assignee
Lawrence Livermore National Security LLC
|
Original Assignee
Regents of the University of California
|
Gene delivery by microneedle injection | ||
Patent #
US 5,697,901 A
Filed 05/19/1995
|
Current Assignee
Applied Tissue Technologies LLC
|
Original Assignee
Elof Eriksson
|
Intradermal drug delivery device and method for intradermal delivery of drugs | ||
Patent #
US 5,527,288 A
Filed 01/18/1994
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Original Assignee
Elan Medical Technologies Ireland Ltd.
|
Interstitial fluid collection and constituent measurement | ||
Patent #
US 5,582,184 A
Filed 10/11/1994
|
Current Assignee
Integ Incorporated
|
Original Assignee
Integ Incorporated
|
Method for fabricating a substrate having spaced apart microcapillaries thereon | ||
Patent #
US 5,383,512 A
Filed 05/24/1993
|
Current Assignee
Midwest Research Institute
|
Original Assignee
Midwest Research Institute
|
Apparatus for injecting a substance into the skin | ||
Patent #
US 5,401,242 A
Filed 02/25/1993
|
Current Assignee
Harold Yacowitz
|
Original Assignee
Harold Yacowitz
|
Needle array and method of introducing biological substances into living cells using the needle array | ||
Patent #
US 5,457,041 A
Filed 03/25/1994
|
Current Assignee
Leidos Inc.
|
Original Assignee
Science Applications International Corporation
|
Transdermal or interdermal drug delivery devices | ||
Patent #
US 5,279,544 A
Filed 11/25/1992
|
Current Assignee
Elan Pharma International Limited
|
Original Assignee
SIL MEDICS LTD.
|
Intradermal injection device | ||
Patent #
US 5,279,552 A
Filed 01/11/1993
|
Current Assignee
Anton Magnet
|
Original Assignee
Anton Magnet
|
Allergy testing method and apparatus | ||
Patent #
US 5,335,670 A
Filed 08/17/1992
|
Current Assignee
Henry Fishman
|
Original Assignee
Henry Fishman
|
Microneedle for injection of ocular blood vessels | ||
Patent #
US 5,364,374 A
Filed 09/24/1993
|
Current Assignee
State of Oregon
|
Original Assignee
State of Oregon
|
Transdermal administration method of protein or peptide drug and its administration device thereof | ||
Patent #
US 5,250,023 A
Filed 10/29/1990
|
Current Assignee
Korea Research Institute of Chemical Technology
|
Original Assignee
Korean Research Institute on Chemical Technology
|
Field emission cathode of bio-molecular or semiconductor-metal eutectic composite microstructures | ||
Patent #
US 5,138,220 A
Filed 12/05/1990
|
Current Assignee
Science Applications International Corporation
|
Original Assignee
Science Applications International Corporation
|
Transcutaneously implantable element | ||
Patent #
US 5,035,711 A
Filed 09/05/1990
|
Current Assignee
Kabushiki Kaisya Advance Kaihatsu Kenkyujo
|
Original Assignee
KABUSHIKI KAISYA ADVANCE KAIHATSU KENKYUJO
|
Tattooing assembly | ||
Patent #
US 5,054,339 A
Filed 12/19/1990
|
Current Assignee
Harold Yacowitz
|
Original Assignee
Harold Yacowitz
|
Transdermal drug patch with microtubes | ||
Patent #
US 4,921,475 A
Filed 05/20/1988
|
Current Assignee
Drug Delivery Systems Incorporated
|
Original Assignee
Drug Delivery Systems Incorporated
|
Electrode array for use in connection with a living body and method of manufacture | ||
Patent #
US 4,969,468 A
Filed 01/24/1989
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Needle cartridge | ||
Patent #
US 4,798,582 A
Filed 10/27/1987
|
Current Assignee
Permark Incorporated
|
Original Assignee
Permark Incorporated
|
Needle holder | ||
Patent #
US 4,771,660 A
Filed 08/24/1987
|
Current Assignee
Harold Yacowitz
|
Original Assignee
Harold Yacowitz
|
Subatmospheric method and apparatus for expanding blood vessels to facilitate puncture with a cannula | ||
Patent #
US 4,664,651 A
Filed 03/01/1985
|
Current Assignee
Procter Gamble Company
|
Original Assignee
Procter Gamble Company
|
Electrochemical cell sensor for continuous short-term use in tissues and blood | ||
Patent #
US 4,671,288 A
Filed 06/13/1985
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Blood sampling device for obtaining small quantity of venous blood | ||
Patent #
US 4,703,761 A
Filed 08/04/1986
|
Current Assignee
Robert A. Levine
|
Original Assignee
William W. Jones
|
Osmotically driven fluid dispenser | ||
Patent #
US 4,320,758 A
Filed 12/08/1980
|
Current Assignee
ALZA Corporation
|
Original Assignee
ALZA Corporation
|
Allergy testing device with vented base | ||
Patent #
US 4,222,392 A
Filed 05/23/1979
|
Current Assignee
KRUEGER JANE 30 BRENNAN LOUIS G. 70 BRENNAN CYNTHIA B. 70 BOTH JOINTLY A SEVENTY PERCENT 70 UNDIVIDED INTEREST
|
Original Assignee
ALIER-SCREEN INC.
|
Electrical marking device | ||
Patent #
US 4,159,659 A
Filed 05/16/1978
|
Current Assignee
Carol Nightingale
|
Original Assignee
Carol Nightingale
|
Multi-penetration vaccination apparatus | ||
Patent #
US 4,109,655 A
Filed 10/15/1976
|
Current Assignee
Institut Pasteur, Manufacture Francaise dArmes et Cycles de Saint-Etienne Manufrance
|
Original Assignee
Institut Pasteur, Manufacture Francaise dArmes et Cycles de Saint-Etienne Manufrance
|
Drug delivery device | ||
Patent #
US 3,964,482 A
Filed 05/17/1971
|
Current Assignee
ALZA Corporation
|
Original Assignee
ALZA Corporation
|
Intracutaneous injection device | ||
Patent #
US 3,034,507 A
Filed 05/10/1960
|
Current Assignee
Henry E. Zangenberg, Jack B. Mcconnell, Murray S. Cooper
|
Original Assignee
Henry E. Zangenberg, Jack B. Mcconnell, Murray S. Cooper
|
Device for cutaneous therapeutic treatment | ||
Patent #
US 3,918,449 A
Filed 06/05/1974
|
Current Assignee
Michel Louis Paul Pistor
|
Original Assignee
Etablissements A. Guerin, Michel Louis Paul Pistor
|
MULTIPLE PUNCTURE INJECTOR DEVICE | ||
Patent #
US 3,675,766 A
Filed 02/04/1970
|
Current Assignee
Sol Roy Rosenthal
|
Original Assignee
Sol Roy Rosenthal
|
INJECTION DEVICE | ||
Patent #
US 3,596,660 A
Filed 05/12/1969
|
Current Assignee
Melone Robert Richard
|
Original Assignee
Melone Robert Richard
|
Surgical multiple puncture devices | ||
Patent #
US 3,086,530 A
Filed 12/07/1959
|
Current Assignee
Allen Hanburys Limited
|
Original Assignee
Walter Groom
|
Article of manufacture for intracutaneous injections | ||
Patent #
US 2,893,392 A
Filed 01/08/1958
|
Current Assignee
Sam Cooper Murray, Richard Wagner Alan
|
Original Assignee
Sam Cooper Murray, Richard Wagner Alan
|
SKIN ALLERGY TESTING DEVICE | ||
Patent #
US 3,556,080 A
Filed 04/08/1968
|
Current Assignee
LINCOLN LABORATORIES INC.
|
Original Assignee
Gary L. Hein
|
Vaccinating devices | ||
Patent #
US 3,136,314 A
Filed 08/01/1960
|
Current Assignee
Harvey Kravitz
|
Original Assignee
Harvey Kravitz
|
Injection device | ||
Patent #
US 3,221,739 A
Filed 03/26/1962
|
Current Assignee
Roy Rosenthal Sol
|
Original Assignee
Roy Rosenthal Sol
|
Injection device | ||
Patent #
US 3,221,740 A
Filed 08/31/1962
|
Current Assignee
Roy Rosenthal Sol
|
Original Assignee
Roy Rosenthal Sol
|
48 Claims
-
1. A device for collecting a sample of a biological fluid comprising:
-
one or more hollow or porous microneedles, each having a base end and a tip; a substrate to which the base end is attached or integrated; and at least one collection chamber suitable for collecting said sample of said biological fluid, said collection chamber selectably in fluid communication with the base end, and wherein said collection chamber comprises a one-way valve and an upper portion which is formed of a deformable material. - View Dependent Claims (23, 25, 26, 27, 28, 29)
-
-
2. A device for collecting a sample of a biological fluid comprising:
-
one or more hollow or porous microneedles, each having a base end and a tip; a substrate to which the base end is attached or integrated; and at least one collection chamber suitable for collecting said sample of said biological fluid, wherein said collection chamber is selectably in fluid communication with the base end, and comprises a plurality of compartments. - View Dependent Claims (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
-
21. A device for collecting a sample of a biological fluid comprising:
-
one or more hollow or porous microneedles, each having a base end and a tip; a substrate to which the base end is attached or integrated; at least one collection chamber suitable for collecting said sample of said biological fluid, said collection chamber selectably in fluid communication with the base end; and a fracturable or removable barrier for controlling flow through the microneedle, said barrier interposed between the collection chamber and base of the microneedle.
-
-
22. A device for collecting a sample of a biological fluid comprising:
-
one or more hollow or porous microneedles, each having a base end and a tip; a substrate to which the base end is attached or integrated; and at least one collection chamber suitable for collecting said sample of said biological fluid, said collection chamber selectably in fluid communication with the base end, wherein the one or more microneedles has a hollow bore containing a material to modulate the flow of biological fluid through the microneedles into the collection chamber.
-
-
24. A device for collecting a sample of a biological fluid comprising:
-
one or more hollow or porous microneedles, each having a base end and a tip, a length between 500 μ
m and 1 mm and a width between about 1 μ
m and 500 μ
m, and comprising a metal;a substrate to which the base end is attached or integrated; and at least one collection chamber suitable for collecting said sample of said biological fluid, said collection chamber selectably in fluid communication with the base end. - View Dependent Claims (30)
-
-
31. A device for sensing an analyte in a biological fluid comprising:
-
one or more microneedles, each having a base end and a tip, a length between about 500 μ
m and 1 mm and a width between about 1 μ
m and 500 μ
m, and comprising a metal;a substrate to which the base of the microneedle is attached or integrated; and at least one sensor which is selectably in fluid communication with the microneedle. - View Dependent Claims (43, 44, 45, 46, 47, 48)
-
-
32. A device for sensing an analyte in a biological fluid comprising:
-
one or more microneedles, each having a base end and a tip; a substrate to which the base of the microneedle is attached or integrated; and at least one sensor which is selectably in fluid communication with the microneedle, wherein the one or more microneedles has a hollow bore containing a material to modulate the flow of biological fluid through the microneedles into a collection chamber. - View Dependent Claims (33, 34, 35, 36, 37, 38, 39)
-
-
40. A device for sensing an analyte in a biological fluid comprising:
-
one or more microneedles, each having a base end and a tip; and a substrate to which the base of the microneedle is attached or integrated, wherein at least one of the microneedles is or comprises a sensor, and wherein the one or more microneedles has a hollow bore containing a material to modulate the flow of biological fluid through the microneedles into a collection chamber. - View Dependent Claims (41, 42)
-
1 Specification
This application is a continuation-in-part of U.S. patent application Ser. No. 09/316,229, now U.S. Pat. No. 6,334,856, filed May 21, 1999, which is a continuation-in-part of U.S. patent application Ser. No. 09/095,221, now U.S. Pat. No. 6,503,231, filed Jun. 10, 1998. This application claims the benefit of the filing date of U.S. provisional application Ser. No. 60/146,200, filed Jul. 29, 1999.
This invention was made with government support under Contract Number BES-9813321 awarded by the U.S. National Science Foundation. The government has certain rights in the invention.
This invention is generally in the field of devices for the withdrawal and sensing of biological fluids, such as in the analysis of blood glucose levels.
The extraction of analytes through the skin is critical to diabetic patients, who typically must measure blood glucose several times per day in order to optimize insulin treatment and thereby reduce the severe long-term complications of the disease. Currently, diabetics do this by pricking the highly vascularized fingertips with a lancet to perforate the skin, then milking the skin with manual pressure to produce a drop of blood, which is then assayed for glucose using a disposable diagnostic strip and a meter into which the strip fits. This method of glucose measurement has the major disadvantage that it is painful, so diabetics do not like to obtain a glucose measurement as often as is medically indicated. It would therefore be highly useful to be able to obtain a sample of blood, lymph, or interstitial fluid more quickly, using an easier procedure, and relatively noninvasively. It also would be advantageous to be able to repeatedly or continually extract analyte transdermally over a period of time.
Another common technique for withdrawal of bodily fluids, such as for diagnostic purposes, is the use of a needle, such as those used with standard syringes or catheters. While effective for this purpose, needles are invasive and generally cause pain; local damage to the skin at the site of insertion; and bleeding, which can increase the risk of disease transmission. Needle techniques also generally require administration by one trained in its use, and are not preferred for frequent routine use due to the vascular damage caused by repeated punctures. Some proposed alternatives to the needle require the use of (1) lasers or heat to create a hole in the skin, which is inconvenient, expensive, or undesirable for repeated use; (2) electric fields or ultrasound, which also is inconvenient and expensive; or (3) chemical or biological penetration enhancing agents, which can be irritating to the tissue and undesirable for repeated use.
It is therefore an object of the present invention to provide a device for controlled sampling of biological fluids in a minimally-invasive, painless, and convenient manner.
It is another object of the present invention to provide a device for sensing of biological fluids in a minimally-invasive, painless, and convenient manner.
Microneedle devices for controlled sampling of biological fluids in a minimally-invasive, painless, and convenient manner, are provided. The microneedle devices permit in vivo sensing or withdrawal of biological fluids from the body, particularly from or through the skin or other tissue barriers, with minimal or no damage, pain, or irritation to the tissue.
The microneedle device includes one or more microneedles, preferably in a three-dimensional array, a substrate to which the microneedles are connected, and at least one collection chamber and/or sensor in communication with the microneedles. Preferred embodiments further include a means for inducing biological fluid to be drawn through the microneedles and into the collection chamber for analysis. In a preferred embodiment, this induction is accomplished by use of a pressure gradient, which can be created for example by selectively increasing the interior volume of the collection chamber, which includes an elastic or movable portion engaged to a rigid base.
In a preferred embodiment, the microneedle device further comprises means for transduction, storage, transmission, and display of measured values. The microneedle device also preferably includes means for securing the device to a biological barrier during withdrawal or sensing.
Preferred biological fluids for withdrawal and/or sensing include blood, lymph, interstitial fluid, and intracellular fluid. Examples of analytes in the biological fluid to be measured include glucose, cholesterol, bilirubin, creatine, metabolic enzymes, hemoglobin, heparin, clotting factors, uric acid, carcinoembryonic antigen or other tumor antigens, reproductive hormones, oxygen, pH, alcohol, tobacco metabolites, and illegal drugs.
1. The Microneedle Device
The microneedle devices include at least three components: at least one, preferably more, microneedle(s), a substrate to which the base of the microneedle(s) is secured or integrated, and at least one fluid collection chamber and/or sensor that is selectably in communication with at least one microneedle. Typically, the microneedles are provided as a three-dimensional array, in contrast to a device with a single needle or row of needles. The microneedle device can be adapted to be a single-use, disposable device, or can be adapted to be fully or partially reusable.
a. Substrate
The substrate of the device can be constructed from a variety of materials, including metals, ceramics, semiconductors, organics, polymers, and composites. The substrate includes the base to which the microneedles are attached or integrally formed. A fluid collection chamber and/or sensor can be attached to the substrate or formed (e.g., as part of the substrate) to communicate directly with the base of the microneedles.
b. Microneedles
The microneedles function either as a conduit, a sensing element, or a combination thereof. Conduit microneedles can have a porous or hollow shaft. As used herein, the term “porous” means having pores or voids throughout at least a portion of the microneedle structure, sufficiently large and sufficiently interconnected to permit passage of fluid and/or solid materials through the microneedle. As used herein, the term “hollow” means having one or more substantially annular bores or channels through the interior of the microneedle structure, which have a diameter sufficiently large to permit passage of fluid and/or solid materials through the microneedle. The annular bores may extend throughout all or a portion of the needle in the direction of the tip to the base, extending parallel to the direction of the needle or branching or exiting at a side of the needle, as appropriate. A solid or porous microneedle can be hollow. One of skill in the art can select the appropriate porosity and/or bore features required for specific applications. For example, one can adjust the pore size or bore diameter to permit or regulate passage of the particular material to be transported through the microneedle device.
In one embodiment, one or more of the microneedles are coated (if solid, porous, or hollow) and/or at least partially filled (if porous or hollow) with a sensing or diffusion-modifying material.
The microneedles of the device can be constructed from a variety of materials, including metals, ceramics, semiconductors, organics, polymers, and composites. Preferred materials of construction include pharmaceutical grade stainless steel, gold, titanium, nickel, iron, tin, chromium, copper, palladium, platinum, alloys of these or other metals, silicon, silicon dioxide, and polymers. Representative biodegradable polymers include polymers of hydroxy acids such as lactic acid and glycolic acid polylactide, polyglycolide, polylactide-co-glycolide, and copolymers with PEG, polyanhydrides, poly(ortho)esters, polyurethanes, poly(butyric acid), poly(valeric acid), and poly(lactide-co-caprolactone). Representative non-biodegradable polymers include polycarbonate, polymethacrylic acid, ethylenevinyl acetate, polytetrafluoroethylene (TEFLON™), and polyesters.
The microneedles should have the mechanical strength to remain intact for sensing analyte and/or for serving as a conduit for the collection of biological fluid, while being inserted into the skin, while remaining in place for up to a number of days, and while being removed. In embodiments where the microneedles are formed of biodegradable polymers, the microneedle must remain intact at least long enough for the microneedle to serve its intended purpose (e.g., its conduit function). The microneedles should be sterilizable using standard methods, such as ethylene oxide treatment or gamma irradiation. The microneedles can have straight or tapered shafts. A hollow microneedle that has a substantially uniform diameter, which needle does not taper to a point, is referred to herein as a “microtube.” As used herein, the term “microneedle” includes both microtubes and tapered needles unless otherwise indicated. In a preferred embodiment, the diameter of the microneedle is greatest at the base end of the microneedle and tapers to a point at the end distal the base. The microneedle can also be fabricated to have a shaft that includes both a straight (untapered) portion and a tapered portion.
The microneedles can be formed with shafts that have a circular cross-section in the perpendicular, or the cross-section can be non-circular. For example, the cross-section of the microneedle can be polygonal (e.g. star-shaped, square, triangular), oblong, or another shape. The shaft can have one or more bores. The cross-sectional dimensions typically are between about 1 μm and 500 μm, and preferably between 10 μm and 100 μm. The outer diameter is typically between about 10 μm and about 100 μm, and the inner diameter is typically between about 3 μm and about 80 μm.
The length of the microneedles typically is between about 10 μm and 1 mm, preferably between 100 μm and 500 μm, and more preferably between 150 μm and 350 μm. The length is selected for the particular application, accounting for both an inserted and uninserted portion. An array of microneedles can include a mixture of microneedles having, for example, various lengths, outer diameters, inner diameters, cross-sectional shapes, and spacings between the microneedles. Preferably, the microneedles are sized to avoid or minimize contact with nerve endings in the biological tissue, such as the dermis, thereby eliminating or reducing pain when the microneedles are inserted, for example into the skin.
The microneedles can be oriented perpendicular or at an angle to the substrate. Preferably, the microneedles are oriented perpendicular to the substrate to provide structural strength and to permit ease of insertion into the tissue. An array of microneedles can include a mixture of microneedle orientations, heights, spacings, or other parameters. This variation in an array can be useful, for example, if different microneedles are to provide different sensing or insertion functions.
In one embodiment, the microneedle has one or more holes (ports) or slits positioned on the sides of the shaft of a hollow microneedle having a blunt, open, or closed tip. This design may reduce blockage of the conduit, for example, due to tissue or cells when the microneedles are inserted.
In a preferred embodiment of the device, the substrate and/or microneedles, as well as other components, are formed from flexible materials, or have appropriate materials so as to be flexible, to allow the device to fit the contours of the biological barrier, such as the skin, vessel walls, or the eye, to which the device is applied. A flexible device facilitates more consistent penetration during use, since penetration can be limited by deviations in the attachment surface. For example, the surface of human skin is not flat due to dermatoglyphics (i.e. tiny wrinkles) and hair. Conformality of the flexible device to the skin can be further enhanced by using an external force, such as a uniform pressure, to aid insertion of the microneedles into the biological barrier.
c. Collection Chamber
The fluid collection chamber is selectably in connection with the microneedle bores or pores, such that a biological fluid can flow from the tissue surrounding the microneedle, through the microneedle, and into the collection chamber. Typically, the collection chamber is attached to, or integrated into, the substrate. The chamber should function to contain a biological fluid sample so as to permit analysis within the microneedle device or following transfer to a separate analytical device.
The collection chamber can be substantially rigid or readily deformable. The collection chamber can be formed from one or more polymers, metals, ceramics, semiconductor, or combinations thereof. In a preferred embodiment, the collection chamber contains a porous or absorbent material, such as a sponge, gel, or paper or polymeric strip. The material can be permanently contained or removable, and can function as a diagnostic element or substrate for use in analytical devices. The chamber can initially be empty or can contain a gas or one or more reagents in any form (e.g., liquid or solid particles). In one embodiment, at least a portion of the interior walls of the chamber are coated with a reagent for assaying the biological fluid.
In a preferred embodiment, the collection chamber is formed of an elastic material, such as an elastomeric polymer or rubber. For example, the collection chamber can be a collapsed balloon-like pouch that expands when the biological fluid is drawn into the collection chamber.
The collection chamber of a microneedle device can include a plurality of compartments that are temporarily or permanently isolated from one another and/or from a portion of the microneedles in an array. The device can, for example, be provided to collect or sense through different needles at different rates or at different times into the different compartments. Alternatively, some of the different compartments can contain analytical reagents which can be combined with the biological fluid sample, for example, by piercing, or otherwise removing, a barrier between the compartments, so as to allow the materials to mix for analysis.
In a preferred embodiment, the collection chamber is a standard or Luer-Lock syringe adapted to be connected to a microneedle array. See
In another preferred embodiment, the collection chamber is adapted to receive and use standard glucose sensing strips, which can be loaded into the microneedle device before, during, or after the biological fluid is extracted.
Preferred embodiments of the microneedle device are shown in
d. Sensors
The sensing/analyzing function can occur in the microneedle or body of the device (e.g., in the fluid collection chamber), or external to the device following removal of a sample. The sensing device can be in or attached to one or more microneedles, integrated into the substrate, or within or in communication with the fluid collection chamber. Biosensors can be located on the microneedle surface, inside a hollow or porous microneedle, or inside a device in communication with the body tissue via the microneedle (solid, hollow, or porous).
In a preferred embodiment, the microneedle device provides a single-use collection means. In this design, the microneedle array is used to extract a single measurement and then is detached from a reusable base portion, if any, and disposed.
In one embodiment, the microneedle device is adapted to work with “laboratory-on-a-chip” devices, such as manufactured by Caliper Technologies, Palo Alto, Calif. (see, e.g., U.S. Pat. No. 5,852,495 to Parce and U.S. Pat. No. 5,876,675 to Kennedy); Aclara Biosciences, Hayward, Calif. (see, e.g., U.S. Pat. No. 5,858,188 to Soane et al. and U.S. Pat. No. 5,883,211 to Sassi et al.); and Nanogen, San Diego, Calif. (see, e.g., U.S. Pat. Nos. 5,605,662 and 5,632,957 to Heller et al.).
(i). Tapes of Sensors
Useful sensors may include sensors of pressure, temperature, chemicals, pH, and/or electro-magnetic fields. These microneedle biosensors can include four classes of principal transducers: potentiometric, amperometric, optical, and physiochemical. An amperometric sensor monitors currents generated when electrons are exchanged between a biological system and an electrode. Blood glucose sensors frequently are of this type.
Sensing information or signals can be transferred optically (e.g., refractive index) or electrically (e.g., measuring changes in electrical impedance, resistance, current, voltage, or combination thereof). For example, it may be useful to measure a change in the resistance of tissue to an electrical current, wherein different resistances are calibrated to signal that withdrawal has been completed.
In a preferred embodiment, the microneedle device may include an integrated sensor, such as a chemical sensor, biosensor, or other measurement system to form a complete extraction/measurement system. The unit can be constructed to function as a closed loop drug delivery unit, including drug delivery means, analyte recovery means, sensing means to measure the analyte, and control means to provide a signal to the drug delivery means. In a preferred embodiment, the unit would include subunits to withdraw fluid and calculate the concentration of glucose, for example, to determine the amount of insulin needed and deliver that amount of insulin.
The device can include means for assaying the amount of analyte extracted. For example, an assay method that results in a color change could be used. The change in color could be detected using a light beam that enters into a disposable collection chamber through a window on top. The analyte may also be detected in the chamber through the use of an enzyme electrode or biosensor. The analyte sensing system can include enzymes that react with the analyte of interest and either electrochemical or optical transducers that measure the content of reaction. Examples of such enzymes are glucose oxidase and glucose dehydrogenase.
An example of an enzyme electrode for glucose is a screen-printed electrode on the surface of which is immobilized glucose oxidase and an electron mediator such as ferrocene or its derivatives. Electrons generated by the oxidation of glucose are transferred from glucose oxidase to the electrode via the mediator. Thus, the concentration of glucose in the analyte solution is proportional to the current generated. Yet another detection mechanism may be used based on near-infrared spectroscopy. In this method, concentration of extracted glucose in a gel is detected by the absorption of the near-infrared light that passes through the chamber through two windows.
(ii). Microneedle as Sensing Element
In one embodiment, the microneedle is adapted to be the sensing element. For example, an assay material, such as glucose oxidase, can be (i) coated onto the external surface of hollow or solid microneedles, (ii) distributed within the pores of porous microneedles, or (iii) line or fill the bore(s) of hollow microneedles. See
In this embodiment, the assay material contacts the analyte for which it is selective and undergoes a change, such as an oxidation reaction. This change is communicated, either directly or indirectly, to the user. For example, change may be indicated optically (change in color or refractive index) or electrically. Alternatively, the change may induce a shift in pH that can be measured and communicated using conventional techniques. In more complex embodiments, the analyte may be adsorbed to the microneedle or a coating thereon, such that mechanical sensing can be used, for example, by measuring vibration changes caused by the adsorption.
(iii). Sensor Electronics
In a preferred embodiment, the sensors are selectively in communication with an electronics package. The electronics package typically includes a power source (e.g., a battery), as well as electronic hardware and software for the transduction, storage, transmission, and display of measured values. The electronics package can be selectively fixed to the microneedle device, for example, so that the electronics package can be reused with a new, disposable microneedle device. The electronics package can include a mechanism for wireless or wire-based transmission of measured values to a remote device for analysis and/or display. The electronics also may include mathematical manipulation of the sensed data, for example, to average measured values or eliminate outlying datapoints so as to provide more useful measurements.
The electronics package also can include software and hardware to initiate or automate the sensing and analysis processes. It may be desirable to design a microneedle device capable of taking multiple measurements to withdraw/sense samples on a preprogrammed schedule (e.g., periodic or random), for example, to monitor the blood plasma levels of an illegal drug. Such a device could be adapted for use with a transmitter designed to lock onto the wrist or ankle of a drug offender or other probationer. The device would then be able to randomly test the wearer without his knowledge in order to assess his compliance with orders to abstain from drug or alcohol use.
In an alternative embodiment, the electronics package includes a device for controlling the withdrawal or sensing process. For example, sensing could be activated based on elapsed time, body temperature, or in response to an external trigger (e.g., motion sensor or push-button). The electronics package, for example, could provide substantially instantaneous readings of glucose levels by depressing a button, or in a microneedle device (e.g., adapted to be worn for an extended period of time), the electronics could it could display a summary of intermittent glucose measurements taken automatically throughout the day. Such a microneedle device would be highly useful to diabetic patients to routinely monitor their blood glucose levels following insulin dosing, between or following meals, and at other times throughout the day.
(iv). Single Unit Multiple Sensing
A single microneedle device can be designed to provide multiple, preferably sequential, measurements. In a preferred embodiment, the device includes a plurality of discrete fluid collection chambers, each of which is in communication with a defined subset of microneedles in an array of microneedles. The sensing unit of the device can sense each of the collection chambers independently. The sensing can be triggered manually or device electronics can be preprogrammed to automatically trigger, for example at specific time intervals. The device can include a means for storing, displaying, or transmitting the multiple measured values as needed.
(v). Sensor Calibration
Calibration of the sensor can be accomplished using the concentration of a second analyte or the same analyte measured by another means. The primary analyte can be normalized, lowering extraction to extraction and site to site variability, by the concentration of the second analyte or same analyte from a separate measurement. Normalization may be a linear or non-linear relationship.
In a preferred embodiment for glucose sensing, a reusable sensor, which assays glucose concentration in interstitial fluid, can be calibrated daily by correlating interstitial fluid glucose values with values obtained from glucose measurements obtained from blood, similar to the approach used by Cygnus Inc.'"'"'s “Gluco-Watch.”
e. Attachment Feature
In a preferred embodiment, the microneedle device includes an adhesive material to secure the microneedle device to the skin, temporarily immobilizing the microneedles while inserted into the skin to sense or withdraw fluid. The adhesive agent typically is applied to the substrate (in between the microneedles at their base) or to an attachment collar or tabs adjacent the microneedles.
Care must be taken so that any adhesive agent does not plug the bores of hollow microneedles. For example, the adhesive agent can be applied in a liquid solution by flooding the top of the substrate below the tips of the microneedles, such as from the side of an array of microneedles, or by using a three-dimensional printing process or spin coating. The solvent can then be evaporated from the adhesive agent solution, thereby precipitating or gelling the adhesive agent to yield a tacky surface. An alternate method of keeping the tips free of an applied adhesive agent is to choose materials of construction having a hydrophobicity or hydrophilicity to control the wetting of the surface to the microneedle tips.
Where a vacuum is used to induce fluid flow into the device, it may be necessary to provide means for creating a gas-tight seal around the edge of the device so that air is not drawn in through the microneedles at the biological barrier hole/microneedle shaft periphery. The attachment collar or adhesive material can be adapted to provide this function using techniques common to the those skilled in the art. One example is to design the attachment collar to function as a “suction-cup” and wet the interface of the skin and attachment collar with water or another physiologically acceptable sealant.
For sustained use, such as for taking sequential measurements, the device preferably is adapted to be worn by the user, by including a securing means for securing the whole device to the user'"'"'s body. For example, the device can be integrated into an adhesive patch or an elastic band, which may be worn, for example, around the user'"'"'s arm or ankle.
Feedback about Withdrawal
In a preferred embodiment, the microneedle device includes a feedback means so that the user can determine whether withdrawal and/or sensing has been completed. Representative feedback means include a sound, a color (change) indicator, or a change in the position or shape of a reservoir.
2. Manufacture of Microneedles
The microneedle devices are made by microfabrication processes, by creating small mechanical structures in silicon, metal, polymer, and other materials. These microfabrication processes are based on well-established methods used to make integrated circuits, electronic packages and other microelectronic devices, augmented by additional methods used in the field of micromachining. The microneedle devices can have dimensions as small as a few nanometers and can be mass-produced at low per-unit costs.
a. Microfabrication Processes
Microfabrication processes that may be used in making the microneedles disclosed herein include lithography; etching techniques, such as wet chemical, dry, and photoresist removal; thermal oxidation of silicon; electroplating and electroless plating; diffusion processes, such as boron, phosphorus, arsenic, and antimony diffusion; ion implantation; film deposition, such as evaporation (filament, electron beam, flash, and shadowing and step coverage), sputtering, chemical vapor deposition (CVD), epitaxy (vapor phase, liquid phase, and molecular beam), electroplating, screen printing, lamination, stereolithography, laser machining, and laser ablation (including projection ablation). See generally Jaeger, Introduction to Microelectronic Fabrication (Addison-Wesley Publishing Co., Reading Mass. 1988); Runyan, et al., Semiconductor Integrated Circuit Processing Technology (Addison-Wesley Publishing Co., Reading Mass. 1990); Proceedings of the IEEE Micro Electro Mechanical Systems Conference 1987-1998; Rai-Choudhury, ed., Handbook of Microlithography, Micromachining & Microfabrication (SPIE Optical Engineering Press, Bellingham, Wash. 1997); and Madou, Fundamentals of Microfabrication (CRC Press 1997).
The following methods are preferred for making microneedles.
(i). Electrochemical Etching of Silicon
In this method, electrochemical etching of solid silicon to porous silicon is used to create extremely fine (on the order of 0.01 μm) silicon networks which can be used as piercing structures. This method uses electrolytic anodization of silicon in aqueous hydrofluoric acid, potentially in combination with light, to etch channels into the silicon. By varying the doping concentration of the silicon wafer to be etched, the electrolytic potential during etching, the incident light intensity, and the electrolyte concentration, control over the ultimate pore structure can be achieved. The material not etched (i.e. the silicon remaining) forms the microneedles. This method has been used to produce irregular needle-type structures measuring tens of nanometers in width.
(ii). Plasma Etching
This process uses deep plasma etching of silicon to create microneedles with diameters on the order of 0.1 μm or larger. Needles are patterned directly using photolithography, rather than indirectly by controlling the voltage (as in electrochemical etching), thus providing greater control over the final microneedle geometry.
In this process, an appropriate masking material (e.g., metal) is deposited onto a silicon wafer substrate and patterned into dots having the diameter of the desired microneedles. The wafer is then subjected to a carefully controlled plasma based on fluorine/oxygen chemistries to etch very deep, high aspect ratio trenches into the silicon. See, e.g., Jansen, et al., “The Black Silicon Method IV: The Fabrication of Three-Dimensional Structures in Silicon with High Aspect Ratios for Scanning Probe Microscopy and Other Applications,” IEEE Proceedings of Micro Electro Mechanical Systems Conference, pp. 88-93 (1995). Those regions protected by the metal mask remain and form the needles. This method is further described in Example 3 below.
(iii). Electroplating
In this process, a metal layer is first evaporated onto a planar substrate. A layer of photoresist is then deposited onto the metal to form a patterned mold which leaves an exposed-metal region in the shape of needles. By electroplating onto the exposed regions of the metal seed layer, the mold bounded by photoresist can be filled with electroplated material. Finally, the substrate and photoresist mold are removed, leaving the finished microneedle array. The microneedles produced by this process generally have diameters on the order of 1 μm or larger. See, e.g., Frazier, et al., “Two dimensional metallic microelectrode arrays for extracellular stimulation and recording of neurons”, IEEE Proceedings of the Micro Electro Mechanical Systems Conference, pp. 195-200 (1993).
(iv). Other Processes
Another method for forming microneedles made of silicon or other materials is to use microfabrication techniques such as photolithography, plasma etching, or laser ablation to make a mold form (A), transferring that mold form to other materials using standard mold transfer techniques, such as embossing or injection molding (B), and reproducing the shape of the original mold form (A) using the newly-created mold (B) to yield the final microneedles (C). Alternatively, the creation of the mold form (A) could be skipped and the mold (B) could be microfabricated directly, which could then be used to create the final microneedles (C).
Another method of forming solid silicon microneedles is by using epitaxial growth on silicon substrates, as is utilized by Containerless Research, Inc. (Evanston, Ill., USA) for its products.
b. Hollow or Porous Microneedles
In a preferred embodiment, microneedles are made with pores or other pathways through which material may be transported. The following descriptions outline representative methods for fabricating either porous or hollow microneedles.
(i). Porous Microneedles
Rather than having a single, well-defined hole down the length of the needle, porous needles are filled with a network of channels or pores which allow conduction of fluid or energy through the needle shaft. It has been shown that by appropriate electrochemical oxidation of silicon, pore arrays with high aspect ratios and a range of different pore size regimes can be formed; these pore regimes are defined as (1) microporous regime with average pore dimensions less than 2 nm, (2) mesoporous regime with average pore sizes of between 2 nm and 50 nm, and (3) macroporous regime with pores greater than 50 mm. The mesoporous and macroporous regimes are expected to be most useful for drug delivery. Two approaches to porous needles are generally available, either (a) the silicon wafer is first made porous and then etched as described above to form needles or (b) solid microneedles are etched and then rendered porous, for example, by means of electrochemical oxidation, such as by anodization of a silicon substrate in a hydrofluoric acid electrolyte. The size distribution of the etched porous structure is highly dependent on several variables, including doping kind and illumination conditions, as detailed in Lehmann, “Porous Silicon—A New Material for MEMS”, IEEE Proceedings of the Micro Electro Mechanical Systems Conference, pp. 1-6 (1996). Porous polymer or metallic microneedles can be formed, for example, by micromolding a polymer containing a volatilizable or leachable material, such as a volatile salt, dispersed in the polymer or metal, and then volatilizing or leaching the dispersed material, leaving a porous polymer matrix in the shape of the microneedle.
(ii). Hollow Needles
Three-dimensional arrays of hollow microneedles can be fabricated, for example, using combinations of dry etching processes (Laermer, et al., “Bosch Deep Silicon Etching: Improving Uniformity and Etch Rate for Advanced MEMS Applications,” Micro Electro Mechanical Systems, Orlando, Fla., USA, (Jan. 17-21, 1999); Despont et al., “High-Aspect-Ratio, Ultrathick, Negative-Tone Near-UV Photoresist for MEMS”, Proc. of IEEE 10th Annual International Workshop on MEMS, Nagoya, Japan, pp. 518-522 (Jan. 26-30, 1997)); micromold creation in lithographically-defined and/or laser ablated polymers and selective sidewall electroplating; or direct micromolding techniques using epoxy mold transfers.
One or more distinct and continuous pathways are created through the interior of microneedles. In a preferred embodiment, the microneedle has a single annular pathway along the center axis of the microneedle. This pathway can be achieved by initially chemically or physically etching the holes in the material and then etching away microneedles around the hole. Alternatively, the microneedles and their holes can be made simultaneously or holes can be etched into existing microneedles. As another option, a microneedle form or mold can be made, then coated, and then etched away, leaving only the outer coating to form a hollow microneedle. Coatings can be formed either by deposition of a film or by oxidation of the silicon microneedles to a specific thickness, followed by removal of the interior silicon. Also, holes from the backside of the wafer to the underside of the hollow needles can be created using a front-to-backside infrared alignment followed by etching from the backside of the wafer.
a. Silicon Microneedles
One method for hollow needle fabrication is to replace the solid mask used in the formation of solid needles by a mask that includes a solid shape with one or more interior regions of the solid shape removed. One example is a “donut-shaped” mask. Using this type of mask, interior regions of the needle are etched simultaneously with their side walls. Due to lateral etching of the inner side walls of the needle, this may not produce sufficiently sharp walls. In that case, two plasma etches may be used, one to form the outer walls of the microneedle (i.e., the ‘standard’ etch), and one to form the inner hollow core (which is an extremely anisotropic etch, such as in inductively-coupled-plasma “ICP” etch). For example, the ICP etch can be used to form the interior region of the needle followed by a second photolithography step and a standard etch to form the outer walls of the microneedle.
Alternatively, this structure can be achieved by substituting the chromium mask used for the solid microneedles described in Example 3 by a silicon nitride layer 94 on the silicon substrate 95 covered with chromium 96, deposited as shown in
Another method uses the solid silicon needles described previously as ‘forms’ around which the actual needle structures are deposited. After deposition, the forms are etched away, yielding the hollow structures. Silica needles or metal needles can be formed using different methods. Silica needles can be formed by creating needle structures similar to the ICP needles described above prior to the oxidation described above. The wafers are then oxidized to a controlled thickness, forming a layer on the shaft of the needle form which will eventually become the hollow microneedle. The silicon nitride is then stripped and the silicon core selectively etched away (e.g., in a wet alkaline solution) to form a hollow silica microneedle.
In a preferred embodiment, an array of hollow silicon microtubes is made using deep reactive ion etching combined with a modified black silicon process in a conventional reactive ion etcher, as described in Example 4 below. First, arrays of circular holes are patterned through photoresist into SiO2, such as on a silicon wafer. Then the silicon can be etched using deep reactive ion etching (DRIE) in an inductively coupled plasma (ICP) reactor to etch deep vertical holes. The photoresist is then removed. Next, a second photolithography step patterns the remaining SiO2 layer into circles concentric to the holes, leaving ring shaped oxide masks surrounding the holes. The photoresist is then removed and the silicon wafer again deep silicon etched, such that the holes are etched completely through the wafer (inside the SiO2 ring) and simultaneously the silicon is etched around the SiO2 ring leaving a cylinder.
This latter process can be varied to produce hollow, tapered microneedles. After an array of holes is fabricated as described above, the photoresist and SiO2 layers are replaced with conformal DC sputtered chromium rings. The second ICP etch is replaced with a SF6/O2 plasma etch in a reactive ion etcher (RIE), which results in positively sloping outer sidewalls. Henry, et al., “Micromachined Needles for the Transdermal Delivery of Drugs,” Micro Electro Mechanical Systems, Heidelberg, Germany, pp. 494-98 (Jan. 26-29, 1998).
b. Metal Microneedles
Metal needles can be formed by physical vapor deposition of appropriate metal layers on solid needle forms, which can be made of silicon using the techniques described above, or which can be formed using other standard mold techniques such as embossing or injection molding. The metals are selectively removed from the tips of the needles using electropolishing techniques, in which an applied anodic potential in an electrolytic solution will cause dissolution of metals more rapidly at sharp points, due to concentration of electric field lines at the sharp points. Once the underlying silicon needle forms have been exposed at the tips, the silicon is selectively etched away to form hollow metallic needle structures. This process could also be used to make hollow needles made from other materials by depositing a material other than metal on the needle forms and following the procedure described above.
A preferred method of fabricating hollow metal microneedles utilizes micromold plating techniques, which are described as follows and in Examples 5 and 6. In a method for making metal microtubes, which does not require dry silicon etching, a photo-defined mold first is first produced, for example, by spin casting a thick layer, typically 150 μm, of an epoxy (e.g., SU-8) onto a substrate that has been coated with a thin sacrificial layer, typically about 10 to 50 nm. Arrays of cylindrical holes are then photolithographically defined through the epoxy layer, which typically is about 150 μm thick. (Despont, et al., “High-Aspect-Ratio, Ultrathick, Negative-Tone Near-UV Photoresist for MEMS,” Proc. of IEEE 10th Annual International Workshop on MEMS, Nagoya, Japan, pp. 518-22 (Jan. 26-30, 1997)). The diameter of these cylindrical holes defines the outer diameter of the tubes. The upper surface of the substrate, the sacrificial layer, is then partially removed at the bottom of the cylindrical holes in the photoresist. The exact method chosen depends on the choice of substrate. For example, the process has been successfully performed on silicon and glass substrates (in which the upper surface is etched using isotropic wet or dry etching techniques) and copper-clad printed wiring board substrates. In the latter case, the copper laminate is selectively removed using wet etching. Then a seed layer, such as Ti/Cu/Ti (e.g., 30 nm/200 nm/30 nm), is conformally DC sputter-deposited onto the upper surface of the epoxy mold and onto the sidewalls of the cylindrical holes. The seed layer should be electrically isolated from the substrate. Subsequently, one or more electroplatable metals or alloys, such as Pd, Pt, Ni, NiFe, Au, Cu, or Ti, are electroplated onto the seed layer. The surrounding epoxy is then removed, leaving microtubes which each have an interior annular hole that extends through the base metal supporting the tubes. The rate and duration of electroplating is controlled in order to define the wall thickness and inner diameter of the microtubes. In one embodiment, this method was used to produce microtubes having a height of between about 150 and 250 μm, an outer diameter of between about 40 and 120 μm, and an inner diameter of between about 30 and 110 μm (i.e., having a wall thickness of 10 μm). In a typical array, the microtubes have a tube center-to-center spacing of about 150 μm, but can vary depending on the desired needle density.
A variation of this method is preferred for forming tapered microneedles. As described above, photolithography yields holes in the epoxy which have vertical sidewalls, such that the resulting shafts of the microneedles are straight, not tapered. This vertical sidewall limitation can be overcome by molding a preexisting 3D structure, i.e., a mold-insert. The subsequent removal of the mold-insert leaves a mold which can be surface plated similarly to the holes produced by photolithography described above.
Alternatively, non-vertical sidewalls can be produced directly in the polymeric mold into which electroplating will take place. For example, conventional photoresists known in the art can be exposed and developed in such as way as to have the surface immediately adjacent to the mask be wider than the other surface. Specialized greyscale photoresists in combination with greyscale masks can accomplish the same effect. Laser-ablated molds can also be made with tapered sidewalls, e.g., by optical adjustment of the beam (in the case of serial hole fabrication) or of the reticle or mold during ablation (in the case of projection ablation).
To form hollow tapered microneedles, the mold-insert is an array of solid silicon microneedles, formed as described in Henry, et al., “Micromachined Needles for the Transdermal Delivery of Drugs,” Micro Electro Mechanical Systems, Heidelberg, Germany, Jan. 26-29, pp. 494-98 (1998). First, a layer of a material, such as an epoxy (e.g., SU-8) or a polydimethylsiloxane (“PDMS”), is spin cast onto the array of silicon microneedles to completely blanket the entire array. The epoxy settles during pre-bake to create a planar surface above the silicon needle tips; the material is then fully pre-baked, photolithographically cross-linked, and post-baked.
The upper surface of the epoxy is then etched away, for example with an O2/CHF3 plasma, until the needle tips are exposed, preferably leaving between about 1 and 5 μm of tip protruding from the epoxy. The silicon is then selectively removed, for example by using a SF6 plasma or a HNO3/HF solution. The remaining epoxy micromold is the negative of the microneedles and has a small diameter hole where the tip of the microneedle formerly protruded.
After the removal of the silicon, a seed layer, such as Ti—Cu—Ti, is conformally sputter-deposited onto the epoxy micromold. Following the same process sequence described for hollow metal microtubes, one or more electroplatable metals or alloys (such as Ni, NiFe, Au, Pd, Pt, or Cu) are electroplated onto the seed layer. Finally, the epoxy is removed, for example by using an O2/CHF3 plasma, leaving an array of hollow metal microneedles. An advantage of using PDMS in this application is that the micromold can be physically removed from the silicon mold insert by mechanical means, such as peeling, without damaging the silicon mold insert, thus allowing the silicon mold insert to be reused. Furthermore, the electroplated microneedles can be removed from the PDMS mold by mechanical means, for example by peeling, thereby allowing the PDMS to also be reused.
In a preferred embodiment, this method is used to produce microneedles having a height of between about 150 and 350 μm, an outer diameter of between about 40 and 120 μm, and an inner diameter of between about 20 and 100 μm. In a typical array, the microneedles have a center-to-center spacing of between about 150 and 300 μm, but can vary depending on the desired needle density. Tapered microneedles preferably are 200 to 300 μm in height with a base diameter of 80 μm, a tip diameter of 30 μm, and a needle-to-needle spacing of 150 μm.
c. Silicon Dioxide Microneedles
Hollow microneedles formed of silicon dioxide can be made by oxidizing the surface of the silicon microneedle forms (as described above), rather than depositing a metal and then etching away the solid needle forms to leave the hollow silicon dioxide structures. This method is illustrated in
In one embodiment, hollow, porous, or solid microneedles are provided with longitudinal grooves or other modifications to the exterior surface of the microneedles. Grooves, for example, should be useful in directing the flow of molecules along the outside of microneedles.
d. Polymer Microneedles
In a preferred method, polymeric microneedles are made using microfabricated molds. For example, the molds can be made as described herein and injection molding techniques can be applied to form the microneedles in the molds (Weber, et al., “Micromolding—a powerful tool for the large scale production of precise microstructures”, Proc. SPIE—International Soc. Optical Engineer. 2879: 156-67 (1996); Schift, et al., “Fabrication of replicated high precision insert elements for micro-optical bench arrangements” Proc. SPIE—International Soc. Optical Engineer. 3513: 122-34 (1998)). Suitable molds can be formed, for example, from epoxy, silicon, or metal, using or adapting known microfabrication techniques. These micromolding techniques are preferred, as they can provide relatively less expensive replication, i.e. lower cost of mass production. In a preferred embodiment, the polymer is biodegradable.
3. Biological Fluids for Withdrawal or Sensing
The devices disclosed herein are useful in the transport of biological fluids from within or across a variety of biological barriers including the skin (or parts thereof); the blood-brain barrier; mucosal tissue; blood vessels; lymphatic vessels; cell membranes; epithelial tissue; and endothelial tissue. The biological barriers can be in humans or other types of animals, as well as in plants, insects, or other organisms, including bacteria, yeast, fungi, and embryos. In preferred embodiments, biological fluids are withdrawn from skin, more preferably human skin, for minimally invasive diagnostic sensing.
Biological fluids useful with the devices described herein include blood, lymph, interstitial fluid, and intracellular fluid. In a preferred embodiment, the biological fluid to be withdrawn or sensed is interstitial fluid.
A variety of analytes are routinely measured in the blood, lymph or other body fluids. Examples of typical analytes that can be measured include blood sugar (glucose), cholesterol, bilirubin, creatine, various metabolic enzymes, hemoglobin, heparin, hematocrit, vitamin K or other clotting factors, uric acid, carcinoembryonic antigen or other tumor antigens, and various reproductive hormones such as those associated with ovulation or pregnancy. Other substances or properties that would be desirable to detect include lactate (important for athletes), oxygen, pH, alcohol, tobacco metabolites, and illegal drugs (important for both medical diagnosis and law enforcement).
In a preferred embodiment, interstitial fluids are removed from the dermis or epidermis across the stratum corneum to assay for glucose concentration, which is useful in aiding diabetics in determining their required insulin dose.
4. Using the Microneedle Device
The device is applied to the skin or other biological barrier at the site where the sample is to be collected or measured. Then, biological fluid, or a component thereof, is drawn into or through the pores or bores of the microneedles, and optionally collected in the collection chamber. Alternatively, where the microneedles function as the sensor, sensing occurs without transfer of biological fluid into a collection chamber.
a. Feedback about Penetration of the Microneedles into the Tissue
The user of the microneedle device typically can determine if the microneedles have been properly inserted into the skin or other tissue through visual or tactile means, that is assessing whether the substrate has been pressed essentially flush to the tissue surface. A coloring agent can be used to enhance the visual feedback by indicating a color change triggered by biological fluid filing the collection chamber.
In a more complex embodiment, an electrical or chemical measurement is adapted to provide the feedback. For example, penetration can be determined by measuring a change in electrical resistance at the skin or other tissue, or a pH change. Alternately, needle-to-needle electrical resistance can be measured. In a preferred embodiment, the microneedle device includes a disposable cartridge containing the microneedles. In these devices, an LED (e.g., green light/red light) or liquid crystal display can be provided with the reusable portion or the device.
b. Initiating and Controlling Fluid Withdrawal
In a preferred embodiment, the microneedle device is capable of transporting molecules across or from the tissue at a useful rate. That rate will, of course, depend on the particular application. For assaying blood glucose, for example, the device preferably withdraws at least between about 5 and 10 μl of interstitial fluid, preferably in about a minute or less time. For other applications, it may be desirable to apply the device to the barrier for several hours or more in order to monitor the changing blood plasma level of a particular analyte, such as an exogenous drug or hormone level, for example on a real-time basis or to obtain a time-averaged value.
The rate of withdrawal can be controlled by altering one or more of several design variables. For example, the amount of material flowing through the needles can be controlled by manipulating the volumetric through-capacity of a single device array, for example, by using more or fewer microneedles, by increasing or decreasing the number or diameter of the bores in the microneedles, by filling at least some of the microneedle bores with a diffusion-limiting material, or by varying the driving force applied to the biological fluid. It is preferred, however, to simplify the manufacturing process by limiting the needle design to two or three “sizes” of microneedle arrays to accommodate, for example small, medium, and large volumetric flows, for which the withdrawal rate is controlled by other means.
The flow of biological fluid from the tissue through the microneedle and into the collection chamber or into contact with the sensors occurs due to capillary action, diffusion, or is induced using conventional mechanical pumps or nonmechanical driving forces, such as electroosmosis or electrophoresis, thermal gradients, or convection. For example, in electroosmosis, electrodes are positioned on the biological barrier surface, on one or more microneedles, and/or on the substrate adjacent the needles, to create a convective flow which carries charged ionic species and/or neutral molecules toward and/or through at least one of the microneedles.
Transportation of molecules through the microneedles can be controlled or monitored using, for example, various combinations of semi-permeable membranes, valves, pumps, sensors, actuators, and microprocessors. These components can be produced using standard manufacturing or microfabrication techniques. Actuators that may be useful with the microneedle devices disclosed herein include micropumps, microvalves, and positioners.
In a preferred embodiment, the microneedle device is used in combination with another mechanism that enhances the permeability of the biological barrier, for example by increasing cell membrane disruption, using electric fields, ultrasound, chemical enhancers, vacuum, viruses, pH, heat, and/or light. Chemical and/or physical enhancers can be applied to the biological barrier at the site of insertion of the device before or during the withdrawal of the device, for example, to draw analyte closer to the skin surface.
(i). Bulk Flow Extraction
A preferred microneedle device is shown in
Other spring means can be adapted to cause a change in the volume, and thus internal pressure, of the collection chamber. For example, the fluid collection chamber can be adapted to have a movable, rigid top with fixed, rigid side walls, wherein the interface between the walls and top form a gas-tight seal (such as by using a gasket). The volume of the piston-like apparatus can be expanding by activating one or more compressed springs to move the top of the chamber as desired, thereby reducing the pressure in the collection chamber.
In an alternative embodiment, withdrawal can be initiated by activating an osmotic pump, as described, for example, in U.S. Pat. No. 4,320,758 to Eckenhoff, which has been engineered to create a volume expansion/pressure reduction in the collection chamber to draw biological fluid to be drawn into the collection chamber.
In a preferred embodiment, withdrawal is conducted using a microneedle device fitted to a Luer-Lock syringe or similar conventionally-used devices that currently uses hypodermic needles in the barrier penetration method.
(ii). Diffusion-Based Extraction
One preferred embodiment uses diffusion to move the analyte fluid into the fluid collection chamber. A microneedle device using this method generally includes microneedle bores or pores, and/or a fluid collection chamber, that are filled with a diffusion medium, such as water, a saline solution, or a gel, which is physiologically compatible with the biological barrier tissue. Once the needle is inserted into the biological barrier (e.g., the skin), the diffusion medium contacts the biological fluid. Typically, the diffusion medium in the microneedles initially contains none of the analyte to be measured; therefore, analyte at a higher concentration in the biological fluid diffuses into the diffusion medium in the microneedle until a detectable level of analyte in collected or measured. This should be achieved rapidly due to the very small size/length of the microneedles, thereby providing an analyte concentration for sensing that is rapidly response to that in the tissue.
(iii). Hybrid Bulk Flow/Diffusion
In another embodiment, the microneedle device is designed to employ a combination of forces to drive the analyte into the collection chamber. A preferred hybrid design includes the preferred bulk flow microneedle device described above, but with two primary differences. First, the fluid collection chamber has no one-way valve and contains a fluid diffusion medium, preferably physiological saline. Second, a temporary barrier is interposed between the fluid collection chamber and the base of the microneedles. The temporary barrier can be a fracturable membrane, mechanical gate, or other means for containing the diffusion medium within the device until the barrier is broken or removed at a selected time to permit flow of molecules between the microneedles and fluid collection chamber.
In a preferred embodiment, the temporary barrier is an easily fracturable membrane. The device can function as follows: The microneedles first are inserted into the skin of the user. Then the user depresses the elastic cap, causing the fluid diffusion medium to fracture the membrane and fill the bores or pores of the microneedles and contact the biological fluid. After the user releases the elastic cap, it partially or fully returns to its undeformed shape, reducing the pressure in the interior and causing a mixture of the biological fluid and diffusion medium to be drawn through the microneedles and into fluid collection chamber. Once bulk fluid flow ceases, diffusion may continue until the concentration of biological fluid or analyte equilibrates. The mixture can be assayed as described herein, considering the dilution effect induced by the presence of the diffusion medium.
Any of these embodiments of the microneedle device can be adapted to function a series of micro-assays (e.g., as can be provided with an electronics package) or single assays (e.g., standard glucose strips).
e. Multi-Cartridge Microneedle Device
A modification of the disposable, single use microneedle device utilizes a reusable portion providing the withdrawal force (e.g., suction) or electronics package in combination with a cartridge containing one or more, preferably a plurality, of single-use, disposable microneedle devices for collection and/or sensing. For example, the cartridge can be a circular disk having 10 or 12 microneedle arrays connected to a single-assay element, wherein the cartridge can be loaded into and unloaded from the reusable portion. The triggering device can, for example, be designed to move a new microneedle array into position, withdraw or sense the sample of biological fluid, and then eject or immobilize the used microneedle array. This type of reusable triggering device also can include a power source, such as a battery, used to operate a built-in measurement device, for example, for analyte measurement of interstitial fluids.
In one embodiment, the devices are provided in a multipack (e.g., six or twelve pack) form of complete devices, that is, each device is fully sufficient for use. Individual devices can be separated as needed for each sensing measurement.
The present invention will be further understood with reference to the following non-limiting examples.
Studies were performed to demonstrate transport of molecules using either solid silicon microneedles or using hollow silicon microneedles. Transport was measured across human cadaver epidermis in vitro using Franz diffusion chambers at 37° C. using methods described in Henry, et al., “Microfabricated microneedles: A novel method to increase transdermal drug delivery” J. Pharm. Sci. 87:922-25 (1998).
Removal of calcein was measured. Removal refers to the ability to transport calcein from the viable epidermis side of the epidermis to the stratum corneum side. This is the direction of transport associated with removing from the body compounds found in the body, such as glucose. Other compounds were tested for delivery only.
In all cases shown in Table 1, transport of these compounds across skin occurred at levels below our detection limit when no needles were inserted into the skin. When solid microneedles were inserted into the skin and left in place, large skin permeabilities were measured, indicating that the microneedles had created pathways for transport across the skin. Furthermore, in all cases, when solid microneedles were inserted into the skin and then removed, even greater skin permeabilities resulted. Finally, when hollow microneedles were inserted into the skin and left in place, still greater skin permeabilities resulted for those compounds tested. These studies show that microneedles can dramatically increase skin permeability and can thereby increase transport of a number of different compounds across the skin. It also shows that when solid microneedles are used, a preferred embodiment involves inserting and then removing microneedles, rather than leaving them in place. It also shows that using hollow microneedles are a preferred embodiment over the use of solid microneedles.
To demonstrate that fluid can be forced through hollow microneedles at meaningful rates, the flow rate of water through a microneedle array was measures as a function of pressure. The array used contained 100 hollow silicon microneedles having an inner diameter of 50 μm and an outer diameter of 80 μm. The results, which are shown in Table 2, demonstrate that significant flow rates of water through microneedles can be achieved at modest pressures. The measured flow rates are comparable to flow rates through hypodermic needles attached to syringes.
A chromium masking material was deposited onto silicon wafers and patterned into dots having a diameter approximately equal to the base of the desired microneedles. The wafers were then loaded into a reactive ion etcher and subjected to a carefully controlled plasma based on fluorine/oxygen chemistries to etch very deep, high aspect ratio valleys into the silicon. Those regions protected by the metal mask remain and form the microneedles.
<100>-oriented, prime grade, 450-550 μm thick, 10-15 Ω-cm silicon wafers (Nova Electronic Materials Inc., Richardson, Tex.) were used as the starting material. The wafers were cleaned in a solution of 5 parts by volume deionized water, 1 part 30% hydrogen peroxide, and 1 part 30% ammonium hydroxide (J. T. Baker, Phillipsburg, N.J.) at approximately 80° C. for 15 minutes, and then dried in an oven (Blue M Electric, Watertown, Wis.) at 150° C. for 10 minutes. Approximately 1000 Å of chromium (Mat-Vac Technology, Flagler Beach, Fla.) was deposited onto the wafers using a DC-sputterer (601 Sputtering System, CVC Products, Rochester, N.Y.). The chromium layer was patterned into 20 by 20 arrays of 80 μm diameter dots with 150 μm center-to-center spacing using the lithographic process described below.
A layer of photosensitive material (1827 photoresist, Shipley, Marlborough, Mass.) was deposited onto the chromium layer covering the silicon wafers. A standard lithographic mask (Telic, Santa Monica, Calif.) bearing the appropriate dot array pattern was positioned on top of the photoresist layer. The wafer and photoresist were then exposed to ultraviolet (UV) light through the mask by means of an optical mask aligner (Hybralign Series 500, Optical Associates, Inc., Milpitas, Calif.). The exposed photoresist was removed by soaking the wafers in a liquid developer (354 developer, Shipley, Marlborough, Mass.) leaving the desired dot array of photoresist on the chromium layer. Subsequently, the wafers were dipped into a chromium etchant (CR-75; Cyanteck Fremont, Calif.), which etched the chromium that had been exposed during the photolithography step, leaving dot arrays of chromium (covered with photoresist) on the surface of the silicon wafer. The photoresist still present on the chromium dots formed the masks needed for fabrication of the microneedles, described below.
The microneedles were fabricated using a reactive ion etching techniques based on the Black Silicon Method developed at the University of Twente. The patterned wafers were etched in a reactive ion etcher (700 series wafer/batch Plasma Processing System, Plasma Therm, St. Petersburg, Fla.) with means for ensuring good thermal contact between the wafers and the underlying platen (Apiezon N, K. J. Lesker, Clairton, Pa.). The wafers were etched using the following gases and conditions: SF6 (20 standard cubic centimeters per minute) and O2 (15 standard cubic centimeters per minute) at a pressure of 150 mTorr and a power of 150 W for a run time of approximately 250 minutes. These conditions caused both deep vertical etching and slight lateral underetching. By controlling the ratio of flow rates of the SF6 and O2 gases used to form the plasma, the aspect ratio of the microneedles could be adjusted. The regions protected by the chromium masks remained and formed the microneedles. Etching was allowed to proceed until the masks fell off due to underetching, resulting in an array of sharp silicon spikes.
Three-dimensional arrays of microtubes were fabricated from silicon, using deep reactive ion etching combined with a modified black silicon process in a conventional reactive ion etcher. The fabrication process is illustrated in
Hollow metal microtubes were prepared without dry silicon etching, using a thick, photo-defined mold of epoxy. The sequences are illustrated in
A micromold having tapered walls was fabricated by molding a preexisting 3-D array of microneedles, i.e. the mold-insert, and subsequently removing the mold insert. The micromold was then surface plated in a manner similar to that for the microtubes described in Example 5. The fabrication sequence is illustrated in
First, an array of solid silicon microneedles 50 were prepared as described in Henry, et al., “Micromachined Needles for the Transdermal Delivery of Drugs,” Micro Electro Mechanical Systems, Heidelberg, Germany, pp. 494-98 (Jan. 26-29, 1998). Then, a layer of epoxy 52 (SU-8) was spin cast onto the microneedle array to completely blanket the array (
Then, the upper surface of the epoxy 52 was etched away using an O2/CHF3 plasma until approximately 1 to 2 μm of the needle tips 51 were exposed, protruding from the epoxy 52 (
Micromold-based microneedles also have been successfully manufactured using a process in which the epoxy mold material was replaced with PDMS. In this case, it was possible to remove the mold from the mold insert, as well as the microneedles from the mold, using only physical techniques such as peeling. This approach advantageously requires no dry etching and allows one to reuse both the mold and the mold insert.
A micromold having tapered walls was fabricated by use of laser ablation techniques, as shown in
Alternate polymer removal methods, such as thermal, solvent, aqueous, or photo-degradation followed by solvent or aqueous removal, are also possible if the polymer material is chosen appropriately (e.g., a photoresist resin).
Formation of a microneedle by embossing is shown in
Publications cited herein and the material for which they are cited are specifically incorporated by reference. Nothing herein is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.
Modifications and variations of the methods and devices described herein will be obvious to those skilled in the art from the foregoing detailed description. Such modifications and variations are intended to come within the scope of the appended claims.